angiotensin ii has been researched along with enalapril in 507 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 141 (27.81) | 18.7374 |
| 1990's | 200 (39.45) | 18.2507 |
| 2000's | 124 (24.46) | 29.6817 |
| 2010's | 40 (7.89) | 24.3611 |
| 2020's | 2 (0.39) | 2.80 |
| Authors | Studies |
|---|---|
| Altieri, P; De Mello, W | 1 |
| Auch-Schwelk, W; Bossaller, C; Fleck, E; Götze, S; Graf, K; Gräfe, M; Weber, F | 1 |
| Leite, R; Salgado, MC | 1 |
| Admiraal, PJ; Boomsma, F; Derkx, FH; Man in 't Veld, AJ; Ritsema van Eck, HJ; Schalekamp, MA; van den Meiracker, AH | 1 |
| Brunner, D; Brunner, HR; Keller, I; Nussberger, J | 1 |
| Boer, P; Dorhout Mees, EJ; Koomans, HA; Vos, PF | 1 |
| Borghetti, A; Buzio, C; Cabassi, A; Cavalli, R; Cavatorta, A; Coghi, P; De Martin, L; Perazzoli, F; Pucci, F; Regolisti, G | 1 |
| Armstrong, PW; Forster, C; Larosa, G | 1 |
| Bell, L; Luthringer, DJ; Madri, JA; Warren, SL | 1 |
| Blanc, J; Deckert, V; Elghozi, JL; Grichois, ML | 1 |
| Carey, RM; Geary, KM; Gomez, RA; Hunt, MK; Peach, MJ | 1 |
| Hayakawa, M | 1 |
| Carey, RM; Geary, KM; Gomez, RA; Hunt, MK; Norling, LL; Peach, MJ; Ramos, SP | 1 |
| Head, GA; Williams, NS | 1 |
| Bie, P; Emmeluth, C | 1 |
| Brooks, DP; Edwards, RM; Gellai, M; Jugus, J; Ohlstein, EH; Ruffolo, RR; Sulpizio, A; Vickery, L; Weinstock, J | 1 |
| Kitamura, K; Maeda, H; Noguchi, A; Takahashi, T; Takashina, K; Tsurumi, H; Yamaguchi, T | 1 |
| De Mey, JG; Schiffers, PM; Struyker-Boudier, HA | 1 |
| Chai, SY; Jackson, B; Johnston, CI; Kohzuki, M; Mendelsohn, FA; Paxton, D; Perich, R | 1 |
| Higaki, J; Higashimori, K; Katahira, K; Mikami, H; Moriguchi, A; Nagano, M; Nakamaru, M; Nakamura, F; Ogihara, T; Tabuchi, Y | 1 |
| de Jong, PE; de Zeeuw, D; Heeg, JE; van der Hem, GK | 1 |
| Bennett, T; Gardiner, SM; Tomlinson, KC | 1 |
| Donnelly, R; Elliott, HL; Howie, CA; Reid, JL; Sumner, DJ | 1 |
| Baker, KM; Beinlich, CJ; Morgan, HE; White, GJ | 1 |
| Altieri, P; De Mello, WC | 1 |
| Aso, T; Kubota, T | 1 |
| Kato, M; Nagai, M; Nagano, M; Yang, J | 1 |
| Choy, AM; Lang, CC; Rahman, AR; Struthers, AD | 1 |
| Bann, J; Baur, LH; Bruschke, AV; Buis, B; Manger Cats, V; Schipperheyn, JJ; van der Laarse, A; van der Wall, EE; van Dijk, AD | 1 |
| Franco-Saenz, R; Lotshaw, DP; Mulrow, PJ; Oda, H | 1 |
| Beutler, JJ; Boer, P; Dorhout Mees, EJ; Koomans, HA; Rabelink, AJ; Vos, PF | 1 |
| Bräunlich, H; Fleck, C; Sprott, H | 1 |
| Galla, JH; Luke, RG; Rome, L; Walters, EA | 1 |
| Akabane, S; Imanishi, M; Ito, K; Kawamura, M; Kuramochi, M; Matsushima, Y; Omae, T | 1 |
| Kapoor, SC; Krishna, GG | 1 |
| Higuchi, K; Inagami, T; Murakami, T; Nakajo, S | 1 |
| Higashimori, K; Inagami, T; Mikami, H; Nagano, M; Nakamaru, M; Ogihara, T; Tabuchi, Y | 1 |
| Fogo, A; Ichikawa, I; Yared, A; Yoshida, Y | 1 |
| Madeddu, P; Manunta, P; Melis, MG; Pala, F; Patteri, G; Pazzola, A; Pinna Parpaglia, P; Soro, A; Tonolo, G; Troffa, C | 1 |
| Bigorgne, JC; Corvol, P; Denolle, T; Galland, F; Guyene, TT; Rohmer, V; Saint-Adnré, JP; Schambelan, M | 1 |
| Ganten, D; Hellmann, T; Keuneke, C; Metzger, R; Peters, J; Yacullo, R | 1 |
| Randall, RD; Zimmerman, BG | 1 |
| Kawaguchi, H; Sawa, H; Yasuda, H | 1 |
| Braso, MA; Gubert, S; Ortiz, JA; Sacristán, A | 1 |
| Carey, RM; Gomez, RA; Inagami, T; Johns, DW; Peach, MJ | 1 |
| Fagher, B; Henningsen, N; Hulthén, L; Katzman, P; Thulin, T | 1 |
| Abe, Y; Fukui, K; Iwao, H; Kimura, S; Nakamura, A; Tamaki, T | 1 |
| Müller-Schweinitzer, E; Olea-Baza, I | 1 |
| Pelayo, JC; Quan, AH; Shanley, PF | 1 |
| Carl, PL; Cubeddu, LX; Lindley, CM; Negro-Vilar, A; Wetsel, W | 1 |
| Bonde-Petersen, F; Henriksen, O; Hesse, B; Mehlsen, J; Rasmussen, S; Stadeager, C | 1 |
| Blantz, RC; Tucker, BJ | 1 |
| Abe, K; Kanazawa, M; Sato, M; Takeuchi, K; Tanno, M; Yasujima, M; Yoshida, K; Yoshinaga, K | 1 |
| Abe, Y; Fukui, K; Iwao, H; Kimura, S; Nakamura, A; Nakanishi, S; Tamaki, T | 1 |
| Correa, FM; Gutkind, JS; Nazarali, AJ; Saavedra, JM | 2 |
| Drummer, OH; Johnson, H; Kourtis, S | 1 |
| Biollaz, J; Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Birkenhäger, WH; de Leeuw, PW | 1 |
| de Jong, PE; de Zeeuw, D; Navis, GJ | 1 |
| Cody, RJ | 2 |
| Kimura, B; Phillips, MI | 1 |
| Dickstein, K | 1 |
| Bidiville, J; Brunner, HR; Nussberger, J; Porchet, M; Waeber, B; Waeber, G | 1 |
| Kumahara, Y; Nakamaru, M; Ogihara, T; Rakugi, H; Saito, H; Sakaguchi, K; Shima, J | 1 |
| Ahmad, S; Benter, IF; Itskovitz, HD; Levine, S; Roethel, S; Selig, N; Stier, CT; Zuo, HL | 1 |
| Bagby, SP; Fuchs, EF | 1 |
| Fyhrquist, F; Metsärinne, K; Tikkanen, I; Tötterman, J | 1 |
| Bellet, M; Brunner, J; Juillerat, L; Ménard, J; Nussberger, J; Perret, F; Waeber, B | 1 |
| Dluhy, RG; Hollenberg, NK; Smith, K; Taylor, T; Williams, GH | 1 |
| Franco-Saenz, R; Kusano, E; Mulrow, PJ; Shier, DN; Stoner, GD | 1 |
| Maschio, G; Oldrizzi, L; Rugiu, C | 1 |
| Braley, LM; Menachery, A; Rystedt, L; Williams, GH | 1 |
| Belz, GG; Essig, J; Wellstein, A | 1 |
| Thompson, J; Whiteside, CI | 1 |
| Bonde-Petersen, F; Christensen, NJ; Giese, J; Henriksen, O; Hesse, B; Mehlsen, J; Stadeager, C | 1 |
| Brime, JI; Costales, M; Diaz, F; Lopez-Sela, P; Marin, B; Vijande, M | 1 |
| Abe, K; Tanno, M; Yasujima, M; Yoshinaga, K | 1 |
| Ferrier, CP; Gnaedinger, MP; Matthieu, R; Reuter, K; Saxenhofer, H; Shaw, S; Uehlinger, DE; Weidmann, P | 1 |
| Baussant, T; Corvol, P; Huang, H; Michel, JB; Reade, R | 1 |
| Aber, GM; Harding, P; Messenger, A; Stonier, C | 1 |
| Adams, MA; Black, MJ; Bobik, A; Campbell, GR; Campbell, JH | 1 |
| Brunner, HR; Nussberger, J; Waeber, B | 2 |
| Carapelle, E; Carone, MB; Cerasola, G; Contorno, A; Cottone, S; D'Ignoto, G; Fulantelli, MA; Grasso, L | 1 |
| Goodman, SA; Gould, AB | 1 |
| Bendhack, LM; Lindsey, CJ; Paiva, AC | 1 |
| Mazack, EK; Seymour, AA | 1 |
| Gaillard, CA; Koomans, HA; Mees, EJ | 1 |
| Andreatta, SH; Averill, DB; Ferrario, CM; Santos, RA | 1 |
| Bune, AJ; Cain, MD; Chalmers, JP; Morris, MJ; Russell, AE; Southgate, DO; West, MJ; Wing, LM | 1 |
| Leidig, M; Mann, JF; Ritz, E | 1 |
| Bune, AJ; Chalmers, JP; Elliott, JM; Morris, MJ; Russell, AE; West, MJ; Wing, LM | 1 |
| Blantz, RC; Gabbai, FB; Wilson, CB | 1 |
| Carapelle, E; Carone, MB; Cerasola, G; Contorno, A; Cottone, S; D'Ignoto, G; Fulantelli, MA; Grasso, L; Ziletti, T | 1 |
| Brunner, DB; Brunner, HR; Nussberger, J; Waeber, B | 3 |
| Ann, HS; Jackson, RM; Narkates, AJ; Oparil, S | 1 |
| Carretero, OA; Kaldunski, ML; Roman, RJ; Scicli, AG | 1 |
| Moura, AM; Worcel, M | 1 |
| Nahas, G; Trouvé, R | 1 |
| Bell, PD; Harvey, D; Huang, WC; Mitchell, KD; Navar, LG | 1 |
| Wyvratt, MJ | 1 |
| Fregly, MJ; Rowland, NE | 1 |
| Barrett, GL; Morgan, TO; Smith, M | 1 |
| Ajayi, AA; Reid, JL | 1 |
| Harris, PJ; Morgan, TO; Thomas, D | 1 |
| Eto, T; Fukiyama, K; Kimura, Y; Matsumura, K; Muratani, H; Noda, Y | 1 |
| Müller-Schweinitzer, E | 1 |
| Huang, WC; Navar, LG | 1 |
| Edwards, CR; Padfield, PL | 1 |
| Ahn, HS; Baum, T; Coleman, W; Nelson, S; Pula, KK; Rivelli, M; Sabin, C; Sybertz, EJ; Tedesco, R; Watkins, RW | 1 |
| Story, DF; Ziogas, J | 2 |
| Jover, BF; McGrath, BP | 1 |
| Boer, P; Geyskes, GG | 1 |
| Hollenberg, NK; Rabinowe, S; Redgrave, J; Williams, GH | 1 |
| Di Perr, T | 1 |
| Ball, SG; Cleland, JG; Dargie, HJ; East, BW; Ford, I; Gillen, G; Hodsman, GP; Morton, JJ; Robertson, I; Robertson, JI | 1 |
| Bauer, JH; Reams, GP | 2 |
| Arnolda, L; Jackson, B; Jennings, G; Johnston, CI; Kiat, H; Matthews, PG; McGrath, BP | 1 |
| Meydrech, EF; Olsen, ME | 2 |
| Johnson, AL; Price, WA; Stump, JM; Vavala, RF; Wong, PC | 1 |
| Anderson, WP; Korner, PI; Woods, RL | 1 |
| Chevalier, RL; Peach, MJ | 1 |
| Brunner, HR; Gomez, HJ; Nussberger, J; Schaller, MD; Waeber, B | 1 |
| Conner, DP; Danzeisen, JR; Ferguson, RK; Fruncillo, RJ; Rotmensch, HH; Shepley, KJ; Vlasses, PH | 1 |
| Harman, PK; Joob, AW; Kaiser, DL; Kron, IL | 1 |
| Buckner, FS; Chen, FN; Ganong, WF; Wade, CE | 1 |
| Hidaka, H; Oka, H; Sato, R; Sawada, S | 1 |
| Dzau, VJ | 1 |
| Inagami, T; Miyazaki, M; Okamura, T; Toda, N | 1 |
| Rand, MJ; Story, DF; Ziogas, J | 1 |
| Harris, PJ; Skinner, SL; Zhuo, J | 1 |
| Chevalier, RL; Jones, CE | 1 |
| Cumming, AM; Hodsman, GP; Leckie, BJ; Lever, AF; Malatino, LS; Morton, JJ; Robertson, JI; Tillman, DM; Webb, DJ | 1 |
| Levens, NR | 1 |
| Nelson, EB; Pool, JL; Taylor, AA | 1 |
| Bauer, JH; Lal, SM; Reams, GP; Whalen, JJ | 1 |
| Ganten, D; Lang, RE; Moursi, MG; Unger, T | 1 |
| Baker, KM; Khosla, MC | 1 |
| Lang, RE; Leidig, M; Mann, FE; Ritz, E | 1 |
| Hall, C; Karlberg, BE | 1 |
| Hollenberg, NK; Rogacz, S; Williams, GH | 1 |
| Karlberg, BE; Rosenqvist, U | 1 |
| Mitchell, KD; Navar, LG | 1 |
| Dupont, AG; Van der Nipen, P; Van Steirteghem, AC; Vanhaelst, L | 1 |
| Narkates, AJ; Navar, LG; Oparil, S; Rosivall, L | 1 |
| Mento, PF; Wilkes, BM | 1 |
| Lever, AF; Malatino, LS; Robertson, JI; Tillman, DM | 1 |
| Packer, M | 1 |
| Carapelle, E; Carone, MB; Cerasola, G; Contorno, A; Cottone, S; D'Ignoto, G; Grasso, L | 1 |
| Alagna, S; Bandiera, F; Dessì-Fulgheri, P; Glorioso, N; Madeddu, P; Masala, A; Rappelli, A; Rovasio, PP; Rubattu, S; Soro, A | 1 |
| Bonde-Petersen, F; Henriksen, O; Hesse, B; Rasmussen, S; Stadeager, C | 1 |
| Fyhrquist, F; Grönhagen-Riska, C; Karlberg, BE; Ohman, KP; Tikkanen, I | 1 |
| Atlas, SA; Case, DB; Laragh, JH; Yu, ZY | 1 |
| Brown, JJ; Cumming, AM; Davies, DL; East, BW; Hodsman, GP; Lever, AF; Morton, JJ; Murray, GD; Robertson, JI | 1 |
| Blantz, RC; Pelayo, JC; Ziegler, MG | 1 |
| Lazowski, J | 1 |
| Abe, K; Kasai, Y; Kudo, K; Sato, K; Tajima, J; Tanno, M; Tsunoda, K; Yasujima, M; Yoshinaga, K | 1 |
| Anderson, WP; Casley, DJ; Korner, PI; Selig, SE | 1 |
| Cubela, R; Jackson, B; Johnston, CI | 1 |
| Jover, B; Mimran, A | 1 |
| Davies, RO; Gomez, HJ; Irvin, JD; Walker, JF | 1 |
| Casley, D; Cubella, R; Jackson, BJ; Johnston, CI; Larmour, I | 1 |
| DiNicolantonio, R | 1 |
| Espiner, EA; Fitzpatrick, D; Ikram, H; Nicholls, MG | 2 |
| Blaine, EH; Gaul, SL; Reitz, PM; Ribeiro, LT; Sweet, CS | 1 |
| Bensala-Alaoui, A; Corvol, P; Evin, G; Gardes, J; Ménard, J; Michel, JB | 1 |
| Abrams, WB; Davies, RO; Gomez, HJ | 1 |
| Biollaz, J; Brunner, HR; Davies, RO; Gavras, H; Gavras, I; Waeber, B | 1 |
| Böke, T; Malik, KU | 1 |
| Genest, J; Gutkowska, J; Schiffrin, EL; Thibault, G | 1 |
| Ashworth, RW | 1 |
| Materson, BJ | 1 |
| Bayliss, J; MacGregor, GA; Markandu, ND; Morton, JJ; Roulston, JE; Squires, M | 1 |
| Biollaz, J; Brunner, HR; Dürr, J; Gavras, H; Porchet, M | 1 |
| Doussau, MP; Giudicelli, JF; Richer, C | 2 |
| Birkenhäger, WH; de Leeuw, PW; van Soest, GA | 1 |
| Jackson, B; Johnston, CI; McGrath, BP | 1 |
| Brown, JJ; Davies, DL; Fraser, R; Hodsman, GP; Lever, AF; Morton, JJ; Murray, GD; Robertson, JI | 1 |
| Austin, JE; Clark, KE; Holroyd, JC; Siddiqi, TA | 1 |
| Baum, T; Becker, FT; Sybertz, EJ | 1 |
| Fater, DC; Fregly, MJ; Greenleaf, JE | 1 |
| Brunner, HR; Turini, GA; Waeber, B | 1 |
| Davies, RO; Dluhy, RG; Hollenberg, NK; Moore, TJ; Shoback, DM; Williams, GH | 1 |
| Brown, JJ; Cumming, AM; Davies, DL; East, BW; Hodsman, GP; Lever, AF; Morton, JJ; Murray, GD; Robertson, I; Robertson, JI | 1 |
| Gallo, RV; Ganong, WF; Steele, MK | 1 |
| Lefer, AM; Lefer, DJ | 1 |
| Cremer, W | 1 |
| Gillespie, JB; McCaa, RE | 1 |
| Bao, G; Edling, O; Feelisch, M; Gohlke, P; Unger, T | 1 |
| Lemmer, B; Schnecko, A; Witte, K | 1 |
| Kunert-Radek, J; Mucha, S; Pawlikowski, M; Pisarek, H; Sepien, H; Stawowy, A | 1 |
| Hu, TH; Song, YC; Wan, LL; Zhang, YH; Zhu, J | 1 |
| Cockcroft, JR; Goldberg, MR; Ritter, JM; Sciberras, DG | 2 |
| Mimran, A; Ribstein, J; Valentin, JP | 1 |
| Jover, B; Mimran, A; Nafrialdi, N | 1 |
| Morgan, T; Zhang, Y | 1 |
| Brunner, HR; Hagmann, M; Hiesse-Provost, O; Inglessis, N; Insuasty, J; Ménard, J; Nussberger, J; Reid, J | 1 |
| Brunner, HR; Insuasty, J; MacFadyen, RJ; McIntyre, M; Menard, J; Meredith, PA; Reid, JL | 1 |
| Ito, K; Kito, G; Shiomi, M | 1 |
| Ishidoya, S; Klahr, S; Morrissey, J | 1 |
| Ferder, L; Gomez, RA; Harris, JM; Romano, LM; Tufro-McReddie, A | 1 |
| Fitzgibbon, WR; Hutchison, FN; Imamura, A; Lacy, ER; Mackenzie, HS; Ploth, DW | 1 |
| Lane, PH | 1 |
| de Cavanagh, EM; Ercole, L; Ferder, L; Gómez, RA; Inserra, F; Pszenny, V; Romano, LA | 1 |
| Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Iwao, H; Kim, S; Miura, K; Ohta, K; Omura, T; Yukimura, T | 1 |
| Baur, LH; Cats, VM; de Groot, A; Frölich, M; Keirse, MJ; Schipperheyn, JJ; Souverijn, JH; van der Laarse, A; Voogd, PJ; Vroom, TF | 1 |
| Boer, P; Braam, B; Koomans, HA; Vos, PF | 2 |
| Broten, TP; Chakravarty, PK; Gabel, RA; Greenlee, WJ; Kivlighn, SD; Naylor, EM; Patchett, AA; Schaffer, LW; Schorn, TW; Zingaro, GJ | 1 |
| Inada, Y; Ishimura, Y; Kanagawa, R; Nishikawa, K; Wada, T | 1 |
| Arcuri, KE; Goldberg, AI; Gradman, AH; Ikeda, LS; Nelson, EB; Snavely, DB; Sweet, CS | 1 |
| Gorodetsky, E; Weinstock, M | 1 |
| Patel, KP; Zhang, PL | 1 |
| Bjornsson, TD; Bradstreet, TE; Goldberg, MR; Lewis, G; Lipert, S; McWilliams, EJ; Osborne, B; Pivadori, L; Tanaka, WK; Waldman, SA | 1 |
| Fink, GD; Melaragno, MG | 2 |
| Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Kim, S; Miura, K; Ohta, K; Omura, T; Wada, T; Yukimura, T | 2 |
| Benjamin, N; Lyons, D; Webster, J | 1 |
| Barrett, BJ; Foley, R; Hefferton, D; Morgan, J; Parfrey, P | 1 |
| Higaki, J; Mikami, H; Nagano, M; Ogihara, T | 1 |
| Benjamin, N; Lyons, D; Stewart, D; Webster, J | 1 |
| Aviram, M; Brook, JG; Kaplan, M; Keidar, S; Shapira, C | 1 |
| Burcher, E; Byrne, KB; Geraghty, DP; Stewart, BJ | 1 |
| Forster, C; Larosa, G; Naik, GO | 1 |
| Brunner, HR; Burnier, M; Waeber, B | 1 |
| Eydelloth, RS; Hubert, MF; Keenan, KP; Molon-Noblot, S; Owen, RA; Siegl, PK | 1 |
| Nicholson, TM; Rowland, NE | 1 |
| Kjeldsen, K; Nielsen, LB; Nordestgaard, BG; Stender, S | 1 |
| de Bruijn, JH; de Leeuw, PW; Guitard, C; Jacobs, MC; Mellein, B; Thien, T; van Es, PN; van Montfrans, GA; Veerman, DP; Vreugdenhil, G | 1 |
| Dupont, M; Jover, B; Mimran, A; Nafrialdi, N; Saladini, D | 1 |
| Holley, KE; Johnson, CM; Keith, DS; Torres, VE | 1 |
| Allan, DR; Coletti, CM; Hollenberg, NK; Kifor, I; McKnight, JA | 1 |
| Duggin, GG; Harewood, WJ; Horvath, JS; Phippard, AF; Tiller, DJ | 1 |
| Agar, J; Corke, C; Jackson, T | 1 |
| Baker, KM; Beinlich, CJ; Morgan, HE | 1 |
| Bertolino, F; Bessac, AM; John, GW; Jover, B; Maffre, M; Valentin, JP | 1 |
| Abeta, H; Asagami, T; Furukawa, L; Hino, T; Ishii, T; Kushiro, T; Otsuka, Y; Saito, F; Takahashi, A; Tomiyama, H | 1 |
| Christensen, P; Feldt-Rasmussen, B; Jensen, T; Nørgaard, K | 1 |
| Drexler, H; Holtz, J; Meybrunn, M; Riede, UN; Schieffer, B; Seitz, S; Wirger, A | 1 |
| de Jong, PE; de Zeeuw, D; Gansevoort, RT | 1 |
| Agnoli, GC; Borgatti, R; Cacciari, M; Garutti, C; Ikonomu, E; Lenzi, P; Marinelli, M | 1 |
| Crozier, IG; Foy, SG; Frampton, CM; Ikram, H; Nicholls, MG; Richards, AM; Turner, JG | 1 |
| Admiraal, PJ; Derkx, FH; Kleinbloesem, C; Man in 't Veld, AJ; Mulder, P; Schalekamp, MA; van Brummelen, P; van den Meiracker, AH | 1 |
| Leenen, FH; Ruzicka, M | 1 |
| Cornejo, JC; Juncos, L; Pamies-Andreu, E; Romero, JC | 1 |
| da Silva, SV; da Silva, VJ; Salgado, HC; Salgado, MC | 1 |
| Hostetter, TH; Rosenberg, ME; Smith, LJ | 1 |
| Brooks, DP; DePalma, PD; Fredrickson, TA; Ruffolo, RR; Spielman, WS | 1 |
| Higaki, J; Mikami, H; Miyazaki, M; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T; Tomita, N; Zhao, Y | 1 |
| Blaine, EH; Huang, HC; Koepke, JP; Manning, RE; Olins, GM; Reitz, DB; Smits, GJ | 1 |
| Held, P; Sigurdsson, A; Swedberg, K; Wall, B | 1 |
| DiPette, DJ; Lieux, TR; Townsend, RR; Wolfe, RR | 1 |
| Harmsen, E; Leenen, FH; Ruzicka, M; Yuan, B | 1 |
| Carter, DA; Chew, LJ; Murphy, D; Pardy, K | 1 |
| Altieri, PI; Fernández-Martínez, J; González-Fernández, RA; Lugo, JE | 1 |
| Cozza, EN; de Bedners, ME; Gomez-Sanchez, CE; Lantos, CP; Pecci, A | 1 |
| Morris, RS; Paulson, RJ; Wong, IL | 1 |
| Leenen, FH; Ruzicka, M; Skarda, V | 1 |
| Boon, NA; Gray, AJ; Lee, MR; Newby, DE | 1 |
| Belz, GG; de Mey, C; Goldberg, MR; Li, Q; Schroeter, V; Wroblewski, JM | 1 |
| Carmines, PK; Harrison-Bernard, LM | 1 |
| Armstrong, J; Brownfield, MS; Carnes, M; Rittenhouse, PA; Saydoff, JA; Van De Kar, LD | 1 |
| Velasquez, MT | 1 |
| De Mello, WC | 3 |
| Greene, EL; Hostetter, TH; Kren, S | 1 |
| Hannedouche, TP; Lacour, B; Martinez, F; Natov, S; Schmitt, F | 1 |
| Chatani, F; Sato, K; Sato, S | 1 |
| Choppin, A; O'Connor, SE | 1 |
| Clozel, JP; Clozel, M; Gonzales, MF; Heudes, D; Karam, H; Löffler, BM | 1 |
| Duggin, GG; Gillin, A; Harewood, WJ; Lazzaro, V; Mohamed, S; Tiller, DJ; Willis, N | 1 |
| Häggström, J; Hansson, K; Karlberg, BE; Kvart, C; Madej, A; Olsson, K | 1 |
| Miyazaki, M; Okunishi, H; Song, K; Takai, S; Tanaka, T | 1 |
| Assmann, KJ; de Jong, AS; Dijkman, HB; Koene, RA; Mentzel, S; van Son, JP; Wetzels, JF | 1 |
| Jensen, HA; Omvik, P; Tikkanen, I | 1 |
| Angeli, P; Bodin, F; Fogari, R; Heath, R; Hereng, C; Holwerda, NJ; Oddou-Stock, P; Porcellati, C | 1 |
| Beck, FX; Müller, E; Ohno, A; Pfaller, W; Seppi, T | 1 |
| Fogo, A; Freeman, M; Lo, W; Oikawa, T; Vaughan, DE | 1 |
| Makino, N; Sugano, M; Yanaga, T | 1 |
| Barrett, JD; Eggena, P; Lam, K; Leung, FW; Leung, JW; Scremin, OU; Seno, K; Zhu, JH | 1 |
| Azizi, M; Chatellier, G; Guyene, TT; Ménard, J; Wargon, M | 1 |
| Colvill, LM; Giles, ME; McKinley, MJ; Oldfield, BJ | 1 |
| Forster, C; le Tran, Y | 1 |
| Aurell, M; Johnsen, SA; Persson, IB | 1 |
| Aoki, K; Hori, M; Hoshida, S; Igarashi, J; Kuzuya, T; Nishida, M; Tada, M; Yamashita, N | 1 |
| Arendshorst, WJ; Best, CF; Coffman, TM; Kim, HS; Oliverio, MI; Smithies, O | 1 |
| Armstrong, J; Brownfield, M; Henik, RA; Jensen, J | 1 |
| Cohen, A; Erlich, Y; Rosenmann, E; Rosenthal, T | 1 |
| Hayashi, N; Inukai, T; Kometani, M; Nakao, K; Yamamoto, S | 1 |
| Hayashi, N; Kometani, M; Nakao, K; Yamamoto, S | 1 |
| Hudecova, S; Juhaszova, M; Krizanova, O; Masanova, C; Orlicky, J | 1 |
| Allan, DR; De'Oliveira, JM; Fisher, ND; Hollenberg, NK; McKnight, JA; Price, DA; Williams, GH | 1 |
| Anderson, S; Kennefick, TM | 1 |
| Chen, L; Fändriks, L; Holm, M; Johansson, B; Jönson, C; Pettersson, A | 1 |
| Britto, RR; Campagnole-Santos, MJ; Fagundes-Moura, CR; Khosla, MC; Santos, RA | 1 |
| Chevalier, RL; Wolstenholme, JT; Yoo, KH | 1 |
| Higaki, J; Kida, I; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Nakano, N; Ogihara, T; Tomita, N | 1 |
| Fukuda, R; Imura, Y; Matsuo, T; Nagano, H; Nishikawa, K; Noda, M; Ohta, M; Shibouta, Y | 1 |
| Flack, JM; Krieger, EM; Larochelle, P; Marbury, TC; Reeves, RA; Sareli, P | 1 |
| Al-Bander, H; Hutchison, FN; Jones, H; Kaysen, GA; Webster, S | 1 |
| Ferro, CJ; Haynes, WG; Spratt, JC; Webb, DJ | 1 |
| Beinlich, CJ; Morgan, HE; Vitkauskas, KJ | 1 |
| Onuigbo, M | 1 |
| Grupp, LA; Harding, S; Lau, V | 1 |
| Braam, B; Koomans, HA; Turkstra, E | 1 |
| Drexler, H; Schaufelberger, M; Schieffer, E; Swedberg, K | 1 |
| Ambrosio, GB; Ceconi, C; Dalla Libera, L; Facchin, L; Leprotti, C; Serafini, F; Vescovo, G; Volterrani, M | 1 |
| Demeilliers, B; Jover, B; Mimran, A | 1 |
| Kato, H; Mochizuki, S; Suzaka, H; Tajima, S; Takata, Y; Tomiyama, A | 1 |
| Friberg, P; Guron, G; Marcussen, N | 1 |
| Border, WA; Noble, NA; Peters, H | 3 |
| Alpern, RJ; Haynes, S; Melnick, JZ; Pak, CY; Preisig, PA; Sakhaee, K | 1 |
| Struthers, AD; Yee, KM | 1 |
| Leenen, FH; Skarda, V; White, R; Yuan, B | 1 |
| Diamond, JA; Gharavi, A; Henzlova, MJ; Machac, J; Phillips, RA; Roychoudhury, D; Travis, A | 1 |
| Argenziano, L; Trimarco, B | 1 |
| Gavras, H; Gavras, I | 1 |
| Levine, B | 1 |
| Meleń-Mucha, G; Mucha, S; Pawlikowski, M | 1 |
| Agnoli, GC; Borgatti, R; Cacciari, M; Lenzi, P; Marinelli, M; Stipo, L | 1 |
| Aburano, T; Hiramatsu, T; Kawashima, A; Kinuya, S; Konishi, S; Michigishi, T; Shuke, N; Takayama, T; Tega, H; Tonami, N; Watanabe, N; Yamamoto, W; Yokoyama, K | 1 |
| Du, R; Mou, D; Xu, W; Zhu, X | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Aihara, H; Hisa, H; Kasuya, A; Ogawa, H; Satoh, S; Suzuki-Kusaba, M; Yoshida, M | 1 |
| Dukacz, SA; Kline, RL | 1 |
| Hoshi, K; Ichihara, K; Kosugi, T; Nakai, T; Satoh, K | 1 |
| Al-Nimri, MA; Anderson, S; Chapman, JG; Kelly, FJ; Kennefick, TM; Oyama, TT; Thompson, MM | 1 |
| Crkovská, J; Jirsa, M; Seráková, M; Stípek, S; Tesar, V; Vernerová, Z; Zima, T | 2 |
| Anderson, TJ; Charbonneau, F; Elstein, E; Haber, H | 1 |
| Andersen, JL; Andersen, LJ; Bie, P; Sandgaard, NC | 1 |
| Baumeler, HR; Cocco, G; Ettlin, T | 1 |
| Cukon, S; Ennezat, PV; Hammer, A; Infeld, J; Jorde, UP; Le Jemtel, TH; Lisker, J; Sonnenblick, EH; Suryadevara, V | 1 |
| Fujimori, A; Inagaki, O; Matsuda-Satoh, Y; Shibasaki, M; Tokioka, T; Uchida, W; Yanagisawa, I | 1 |
| Eichler, HG; Frossard, M; Joukhadar, C; Müller, M; Schmid, R; Steffen, G | 1 |
| Cho, SI; Jung, JS; Kim, BS; Kim, SJ; Kim, YK; Lim, YT; Woo, JS | 1 |
| deBlois, D; Der Sarkissian, S; Hamet, P; Tea, BS; Touyz, RM | 1 |
| Fisher, ND; Hollenberg, NK; Price, DA; Williams, GH | 1 |
| Bergström, G; Creutz, J; Göthberg, G; Karlström, G; Rudenstam, J | 1 |
| Bancale, E; Cacace, G; Cesano, G; Gigliola, G; Mengozzi, G; Mosso, R; Paradisi, L; Picciotto, G; Piccoli, G; Polloni, R; Roccatello, D; Rossi, D; Sena, LM | 1 |
| Meyer, TW; Olson, JL; Pagtalunan, ME | 1 |
| Gerdes, AM; Harris, J; Lu, W; Said, S; Tamura, T | 1 |
| Laverty, R; Ledingham, JM | 1 |
| Hiramatsu, T; Kawashima, A; Kinuya, S; Konishi, S; Michigishi, T; Shuke, N; Takayama, T; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
| Moridaira, K; Wada, O; Yanagisawa, H | 1 |
| Brown, NJ; Vaughan, DE | 1 |
| Alexander, J; Azizi, M; Goldberg, A; Linhart, A; Ménard, J; Menten, J; Sweet, C | 1 |
| Inada, Y; Nishikawa, K; Ojima, M; Sanada, T; Shibouta, Y; Wada, T | 1 |
| Deutsch, P; Ianosi-Irimie, M | 1 |
| Allikmets, K; Franken, A; Häss, G; Parik, T; Skards, J; Viigimaa, M | 1 |
| Meyer, TW; Olson, JL; Sorooshian, M | 1 |
| Abe, I; Fujii, K; Fujishima, M; Goto, K; Onaka, U | 1 |
| Hayashi, K; Iwamoto, K; Kizawa, Y; Kusama, T; Murakami, H; Saito, K; Sano, M | 1 |
| Grabs, R; Olbrich, HG; Richter, H; Richter, M; Schramm, D; Skupin, M | 1 |
| Iwao, H; Izumi, Y; Kim, S; Yano, M; Yasumoto, H; Zhan, Y | 1 |
| Abe, A; Hosoya, T; Imasawa, T; Kuriyama, S; Tomonari, H | 1 |
| Basso, N; González Bosc, L; Kurnjek, ML; Müller, A | 1 |
| Rong, P; Skinner, SL; Wilkinson-Berka, JL | 1 |
| Dukacz, SA; Feng, MG; Kline, RL; Lee, RM; Yang, LF | 1 |
| Zieleniewski, W | 1 |
| Townsend, RR | 1 |
| Guo, G; Klahr, S; Liapis, H; McCracken, R; Morrissey, J; Tolley, T | 1 |
| Imura, Y; Matsuo, T; Nagano-Tsuge, H; Naka, T; Noda, M; Ohta, M; Sekiguchi, M; Shibouta, Y | 1 |
| Adams, MA; Hale, TM; Heaton, JP; Okabe, H | 1 |
| Draganov, B; Høieggen, A; Os, I | 1 |
| Hojo, Y; Ikeda, U; Shimada, K | 1 |
| Basso, N; González Bosc, LV; Kurnjek, ML; Müller, A; Terragno, NA | 1 |
| Alcorn, D; Anderson, WP; Denton, KM; Lamden, M; Shweta, A | 1 |
| Kolina, IB; Neverov, NI; Shilov, EM; Shvetsov, MIu; Stavrovskaia, EV; Zakharova, EV | 1 |
| Alexander, BT; Cline, FD; Cockrell, K; Granger, JP; Llinas, MT; Sedeek, M | 1 |
| Lewis, W; Stebbins, CL; Warren, JH; Wraa, CE | 1 |
| Bergeron, R; Bülow, J; Galbo, H; Howlett, K; Kjaer, M; Simonsen, L; Skovgaard, D | 1 |
| Cardin, S; Leung, TK; Li, D; Nattel, S; Pang, L; Shinagawa, K; Wang, Z | 1 |
| Achilli, F; Baglivo, J; Calchera, I; Capra, A; Failla, M; Gentile, G; Giannattasio, C; Grappiolo, A; Mancia, G; Meles, E; Sala, L; Vincenzi, A | 1 |
| Blankestijn, PJ; Boer, WH; Bos, WW; Koomans, HA; Tycho Vuurmans, JL | 1 |
| Benedict, CR; Fowler, MB; Liss, CL; Tang, WH; Vagelos, RH; Willson, K; Yee, YG | 1 |
| Huang, X; Li, D; Lu, H; Wang, Z; Wei, H; Zhan, Y | 1 |
| Navar, LG; Nishiyama, A; Seth, DM | 1 |
| Brunner, HR; Jensen, C; Nussberger, J; Wuerzner, G | 1 |
| Guo, Z; Lai, W; Li, J; Li, S; Liang, X; Liu, Y; Wu, P; Xiu, J; Zhang, Y; Zhong, S | 1 |
| Campbell, DJ; Mackie, FE; Meyer, TW | 1 |
| Iwasaka, T; Masaki, H; Matsubara, H; Nishikawa, M; Nishiue, T; Shibasaki, Y | 1 |
| Berezin, AE; Vizir, VA | 1 |
| Nakamura, A; Niimi, R; Yanagawa, Y | 1 |
| Boner, G; Erman, A; van Dijk, DJ | 1 |
| Chen, Q; Feng, L; Gordon, KL; Han, L; Johnson, RJ; Kanellis, J; Kang, DH; Lan, HY; Mazzali, M; Nakagawa, T; Watanabe, S; Xia, YY | 1 |
| Guo, Z; Lai, W; Li, J; Li, S; Liu, Y; Wu, P; Xiu, JC; Xu, JP; Zhang, Y | 1 |
| Andoh, TF; Bennett, WM; Isaac, J; Shihab, FS; Yi, H | 1 |
| Tsui, JK; Wong, NL | 1 |
| Beevers, DG; Jilma, B; Li-Saw-Hee, FL; Lip, GY; Wagner, OF | 1 |
| Hollenberg, NK | 1 |
| Cheon, HW; Choi, JH; Hong, YS; Kim, CH; Kim, KB; Kim, SK; Lee, JW; Yoo, KH | 1 |
| Abdi, R; Dong, VM; Lee, CJ; Ntoso, KA | 1 |
| Fitzgerald, M; Guo, G; Klahr, S; McCracken, R; Moridaira, K; Morrissey, J; Tolley, T | 1 |
| Basso, N; Boveris, A; Costa, LE; D'Amico, G; Kurnjek, ML; La-Padula, P; Lores-Arnaiz, S | 1 |
| Ashton, N; Sahajpal, V | 1 |
| Maliszewska-Scislo, M; Rossi, NF; Scislo, TJ | 1 |
| Goldstein, BE; Robertson, KL; Rowland, NE | 1 |
| Qui, XS; Sim, MK | 1 |
| Curtis, JR; Miller, JA; Sochett, EB | 1 |
| Brands, MW; Cloud, LJ | 1 |
| Ariza-Nieto, P; Fine, DM; Osborn, JW | 1 |
| Pikalova, VM; Postupaev, VV; Timoshin, SS | 1 |
| Fujimiya, T; Naito, K; Shiraishi, K; Yoshida, K | 1 |
| Hayashi, N; Hori, M; Horimoto, M; Irie, T; Kakiuchi, Y; Kawai, N; Kawano, S; Kimura, A; Komori, M; Murata, H; Nishida, T; Sasaki, Y; Tsuji, S; Tsujii, M; Yasumaru, M | 1 |
| Menrad, A; Orzechowski, HD; Paul, M; Schirner, M; Siemeister, G; Walther, T | 1 |
| Elías, MM; García, VM; Monasterolo, LA | 1 |
| Cardin, S; Leung, TK; Li, D; Nattel, S; Thorin, E; Thorin-Trescases, N | 1 |
| Ciriello, J; Rosas-Arellano, MP; Solano-Flores, LP | 1 |
| Boonyen, M; Futrakul, N; Futrakul, P; Patumraj, S; Siriviriyakul, P; Tosukhowong, P | 1 |
| Cruden, NL; Fox, KA; Newby, DE; Webb, DJ; Witherow, FN | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Tachikawa, H; Takahashi, T; Watanabe, K; Wen, J; Yamaguchi, K | 1 |
| Arneja, AS; Dhalla, NS; Ganguly, PK; Netticadan, T; Shah, KR | 1 |
| Anderson, I; Border, WA; Huang, Y; McCourt, M; Noble, NA; Yu, L | 1 |
| Fowler, MB; Tang, WH; Vagelos, RH; Yee, YG | 1 |
| da Cunha, V; Deng, G; Ho, JJ; Martin-McNulty, B; Rutledge, JC; Sullivan, ME; Tham, DM; Vergona, R; Wang, YX; Wilson, DW | 1 |
| Dimayuga, CA; Homma, S; Jorde, UP; Katz, SD; Le Jemtel, TH; Rizkala, A; Vittorio, TJ | 1 |
| Boomsma, F; de Jong, PE; Kocks, MJ; Lely, AT; Navis, G | 1 |
| Barat, A; Bosch, RJ; Esbrit, P; Gazapo, R; González, L; Izquierdo, A; Ortega, A; Rámila, D | 1 |
| Davidson, WR; Liu, ML; McCue, P; Sharma, K; Williams, KJ; Xu, X; Zhu, Y | 1 |
| Blanchet, M; Curnier, D; De Champlain, J; Ducharme, A; Lamoureux, MC; Racine, N; Sheppard, R; Sirois, P; Tardif, JC; White, M | 1 |
| Hu, G; Xue, C; Yang, J | 1 |
| Gordon, SE; Westerkamp, CM | 1 |
| Du, GY; Sun, XF; Wang, DQ; Wang, W; Zhao, DZ | 1 |
| Alenina, N; Bader, M; Becker, M; Gembardt, F; Krause, W; Maul, B; Pankow, K; Siems, WE; Walther, T | 1 |
| Eiam-Ong, S; Sueblinvong, T; Udom, J | 1 |
| Gündüz, F; Kuru, O; Sentürk, UK | 1 |
| Chen, Y; Friberg, P; Johansson, BR; Lasaitiene, D; Mildaziene, V; Nauciene, Z; Sundelin, B; Yano, M | 1 |
| Jandrasits, K; Luksch, A; Polak, K; Schmetterer, L; Wimpissinger, B | 1 |
| Claverie, F; Flores, C; García, J; León, C; Milena, FJ; Mora, C; Navarro, JF | 1 |
| Kost, CK; Martin, DS; Song, J | 2 |
| Cordaillat, M; Jover, B; Mimran, A; Rugale, C | 1 |
| Bayorh, MA; Eatman, D; Mann, G; Walton, M | 1 |
| Devereux, RB; Krauser, DG | 1 |
| Hirata, A; Igarashi, M; Kadomoto, Y; Tominaga, M | 1 |
| Castro, P; Collantes, P; Copaja, M; Diaz-Araya, G; Godoy, I; Jalil, JE; Lavandero, S; Ocaranza, MP; Pinto, M; Ramirez, C; Roman, M; Varas, M | 1 |
| Bahlmann, L; Heinze, H; Heringlake, M; Klaus, S; Pagel, H; Wagner, K; Wergeland, R; Will, B | 1 |
| Elmarakby, AA; Imig, JD; Pollock, DM; Pollock, JS; Williams, JM | 1 |
| Hayashi, Y; Kamata, K; Kobayashi, T; Matsumoto, T; Taguchi, K | 1 |
| Bakker, SJ; Boomsma, F; Dullaart, RP; Krikken, JA; Lely, AT; Navis, G; Wolffenbuttel, BH | 1 |
| Basso, N; Cini, R; Ferder, L; Inserra, F; Pietrelli, A; Terragno, NA | 1 |
| Bader, M; Heilig, M; Lidström, J; Marquitz, M; Rimondini, R; Siems, WE; Sommer, WH | 1 |
| Hoshikawa, S; Ito, S; Mori, K; Nakagawa, Y; Ozaki, H; Tani, J; Yoshida, K | 1 |
| Brooks, RM; Faraci, FM; Heistad, DD; Lund, DD | 1 |
| Grabowski, EF; Ingelfinger, JR; Kushak, RI; Nestoridi, E; Tsukurov, O | 1 |
| Boomsma, F; Boonstra, AH; Navis, G; Titia Lely, A; Visser, FW | 1 |
| Dorsett-Martin, W; Iliescu, R; Reckelhoff, JF; Sartori-Valinotti, JC; Yanes, LL | 1 |
| Khraibi, AA; Yu, T | 1 |
| Feng, YL; Qiu, T; Tang, YJ; Xiao, J; Xu, ZB | 1 |
| Afzal, R; Floras, J; McKelvie, RS; Rouleau, JL; White, M; Yusuf, S | 1 |
| Glover, PH; Reckelhoff, JF; Ryan, MJ; Sartori-Valinotti, JC; Venegas-Pont, M | 1 |
| Briggs, JP; Chen, L; Chen, M; Eisner, C; Gomez, RA; Huang, Y; Kim, SM; Li, L; Mizel, D; Oppermann, M; Schnermann, J; Sequeira Lopez, ML; Weinstein, LS | 1 |
| Apablaza, F; Chiong, M; Godoy, I; Gonzalez, L; Hernandez, C; Jalil, JE; Lavandero, S; Lopez, R; Moya, J; Novoa, U; Ocaranza, MP; Pinto, M; Varas, M; Verdejo, H | 1 |
| Anania, V; Antuofermo, E; Baralla, E; Deiana, G; Demontis, MP; Macciotta, NP; Palomba, D; Varoni, MV | 1 |
| Murakami, M; Nakagiri, A; Sunamoto, M; Takeuchi, K | 1 |
| Brockmann, M; Desch, M; Kurtz, A; Meyer, C; Milenkovic, VM; Schweda, F; Strauss, O; Todorov, V | 1 |
| Bengel, FM; Bravo, PE; Dannals, RF; Fukushima, K; Higuchi, T; Javadi, MS; Lautamäki, R; Mathews, WB; Szabo, Z; Xia, J | 1 |
| Han, B; He, Y; Ma, J; Pan, Y; Peng, T; Wang, Y; Wei, M; Xin, P; Zhu, W | 1 |
| Carter, CS; Choi, YJ; Chung, HY; Heo, HS; Kim, JM; Leeuwenburgh, C; Mi Ha, Y; Seo, AY; Ye, BH; Yu, BP | 1 |
| Chen, ZY; Huang, Y; Lau, CW; Leung, FP; Tian, XY; Wong, WT; Yao, X; Yung, LH; Yung, LM | 1 |
| Aziz, H; Bedja, D; Chen, Y; Dietz, HC; Doyle, JJ; Habashi, JP; Holm, TM; Judge, DP; Modiri, AN; Schoenhoff, F | 1 |
| Harty, DWS; Hunter, N | 1 |
| Becari, C; Oliveira, EB; Salgado, MC; Teixeira, FR | 1 |
| Capogrosso, RF; Cozzoli, A; De Luca, A; Dinardo, MM; Gagliardi, S; Longo, V; Montagnani, M; Nico, B; Sblendorio, VT | 1 |
| Alexander, BT; Black, JT; Dasinger, JH; Intapad, S; Ojeda, NB; Royals, TP; Tull, FL | 1 |
| Domingo, R; Redondo, JI; Satué, K | 1 |
| Casarini, DE; De Angelis, K; de Oliveira, EM; Fernandes, T; Irigoyen, MC; Malfitano, C; Mostarda, C; Oliveira, EM; Pazzine, M; Ronchi, FA; Rosa, K; Wichi, RB | 1 |
| Balakrishnan, A; Cassis, LA; Charnigo, R; Daugherty, A; Howatt, DA; Liau, G; Lu, H; Wu, C | 1 |
| Huang, J; Huang, X; Jin, H; Wang, D; Zheng, J | 1 |
| Cardoso, LM; Chianca, DA; da Silva, LG; de Menezes, RC; Fernandes, LG; Ferreira, AJ; Foureaux, G; Gomide, JM; Lima, MP; Miranda, PH; Pesquero, JL; Silva, FC | 1 |
| Aires, RS; Cabral, EV; Luzardo, R; Nascimento, WS; Oliveira, FS; Paixão, AD; Silva, PA; Vieira-Filho, LD; Vieyra, A | 1 |
| Laeer, S; Ramusovic, S | 1 |
| Deng, Y; Fang, H; Huang, J; Li, L; Luo, M; Shen, Y; Xu, H; Zheng, H | 1 |
| Alexander, BT; Ojeda, NB; Royals, TP | 1 |
| Brandan, E; Cabello-Verrugio, C; Cabrera, D; Céspedes, C; Morales, MG; Vazquez, Y; Vio, CP | 1 |
| Cassis, LA; Chen, X; Daugherty, A; Lu, H; Tashiro, K; Zhao, M | 1 |
| Brewer, J; Dechend, R; Herse, F; Lamarca, B; Liu, R; Lu, Y; Martin, JN; Moseley, J; Scott, J; Wallace, K; Wallukat, G | 1 |
| Arai, KY; Kikuta, A; Matsuura-Hachiya, Y; Nishiyama, T; Ozeki, R | 1 |
| Djafarzadeh, S; Fahrner, R; Jakob, SM; Jeger, V; Lensch, M; Pereira, AJ; Takala, J | 1 |
| Hall, SE; Kwon, OS; Morton, AB; Powers, SK; Smuder, AJ; Sollanek, KJ; Talbert, EE; Toklu, HZ; Tumer, N; Wiggs, MP | 1 |
| Alexander, BT; Intapad, S; Ojeda, NB; Royals, TP; Varney, E | 1 |
| Hernández-Fonseca, JP; Mosquera, J; Pedreañez, A; Peña, C; Viera, N | 1 |
| Costa, AR; de Souza Júnior, A; Feitosa, LC; Gonçalves, GK; Honorato-Sampaio, K; Machado, FB; Pereira, AM; Reis, AM; Santos, RA | 1 |
| Baum, M; Elmaghrabi, A; Gattineni, J; Legan, SK; Mansuri, A | 1 |
| Li, C; Wang, G; Wu, J; Yuan, W; Zhang, Q | 1 |
| Beanlands, RS; Burns, KD; Croteau, E; DaSilva, JN; deKemp, RA; Hadizad, T; Ismail, B | 1 |
| Bae, ES; Hong, YS; Yim, HE; Yoo, KH | 1 |
| Biojone, C; Casarotto, PC; Castrén, E; Diniz, CRAF; Fred, SM; Joca, SRL | 1 |
| Bratlie, SO; Casselbrant, A; Edebo, A; Fändriks, L; Wallenius, V | 1 |
| Abouelkheir, M; El-Metwally, TH | 1 |
| Agra, RM; Almengló, C; Álvarez, E; Couselo-Seijas, M; Eiras, S; García-Acuña, JM; González-Juanatey, JR; González-Peteiro, M; Varela-Román, A | 1 |
| Asgharzadeh, F; Askarnia-Faal, MM; Avan, A; Daghiani, M; Hassanian, SM; Khazaei, M; Naimi, H; Nazari, SE; Sayyed-Hosseinian, SH; Vahedi, E | 1 |
16 review(s) available for angiotensin ii and enalapril
| Article | Year |
|---|---|
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
Evolution of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Design; Enalapril; Heart Failure; Humans; Hypertension; Renin-Angiotensin System | 1988 |
Angiotensin-converting enzyme inhibitors: past, present, and bright future.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Drug Eruptions; Drug Interactions; Enalapril; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Neutropenia; Proline; Taste Disorders | 1985 |
Significance of the vascular renin-angiotensin pathway.
Topics: Angiotensin II; Animals; Blood Vessels; Captopril; Enalapril; Humans; Hypertension; Hypertension, Renovascular; Receptors, Adrenergic, beta; Renin; Renin-Angiotensin System; Vascular Resistance | 1986 |
Pharmacology of angiotensin converting enzyme inhibitors. A review.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Binding Sites; Blood Pressure; Captopril; Eating; Enalapril; Half-Life; Humans; Intestinal Absorption; Kinetics; Oligopeptides; Peptidyl-Dipeptidase A; Renin; Teprotide | 1986 |
Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Glomerular Filtration Rate; Heart Failure; Humans; Renin-Angiotensin System; Risk | 1987 |
[Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Drug Evaluation; Enalapril; Humans; Hypertension; Proline; Renin-Angiotensin System | 1984 |
An overview of the clinical pharmacology of enalapril.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Dipeptides; Drug Administration Schedule; Enalapril; Enalaprilat; Heart Failure; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney; Kidney Failure, Chronic; Norepinephrine; Prostaglandins; Renal Circulation; Renin | 1984 |
Drugs affecting the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Humans; Renin; Renin-Angiotensin System; Teprotide | 1982 |
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Enalapril; Extracellular Matrix Proteins; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Macrophages; Monocytes; Rats; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Triazoles; Ureteral Obstruction | 1995 |
The advantages of angiotensin II antagonism.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Enalapril; Hemodynamics; Humans; Imidazoles; Kidney; Losartan; Renin-Angiotensin System; Tetrazoles | 1994 |
Angiotensin II receptor blockers. A new class of antihypertensive drugs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzothiadiazines; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diuretics; Enalapril; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Multicenter Studies as Topic; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Tetrazoles | 1996 |
Role of angiotensin II in diabetic nephropathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Enalapril; Hemodynamics; Plasma Volume; Rats; Renin-Angiotensin System | 1997 |
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan | 2006 |
90 trial(s) available for angiotensin ii and enalapril
| Article | Year |
|---|---|
Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Administration Schedule; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Single-Blind Method; Time Factors | 1992 |
Platelet angiotensin II in cerebrovascular accident and the effect of angiotensin-converting enzyme inhibitors.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Platelets; Captopril; Enalapril; Humans; Indans; Reference Values | 1992 |
Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Humans; Lisinopril; Male; Middle Aged; Proteinuria; Renal Circulation | 1991 |
Vascular pressor responses in treated and untreated essential hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Doxazosin; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Peptidyl-Dipeptidase A; Phenylephrine; Prazosin; Reflex; Regional Blood Flow; Renin | 1990 |
Renal interactions between the renin-angiotensin system and the sympathetic nervous system in man.
Topics: Adult; Angiotensin II; Blood Pressure; Enalapril; Glomerular Filtration Rate; Heart Rate; Humans; Kidney; Male; Natriuresis; Norepinephrine; Prazosin; Renin-Angiotensin System; Sympathetic Nervous System | 1991 |
Preservation of renal reserve in chronic renal disease.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Dietary Proteins; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Premedication; Renal Circulation | 1991 |
Effect of the circulating renin-angiotensin system on prolactin release in humans.
Topics: Adenoma; Aldosterone; Angiotensin I; Angiotensin II; Captopril; Circadian Rhythm; Enalapril; Humans; Hypertension; Prolactin; Renin; Renin-Angiotensin System; Thyrotropin-Releasing Hormone | 1990 |
Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. A double-blind, randomized study.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Renin; Verapamil | 1990 |
Chronic treatment of hypertensive patients with converting enzyme inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebrovascular Circulation; Clinical Trials as Topic; Coronary Circulation; Enalapril; Heart Rate; Humans; Hypertension; Lipids; Oligopeptides; Peptidyl-Dipeptidase A; Potassium; Rats; Rats, Inbred SHR; Renin; Sodium; Teprotide | 1986 |
Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Heart Failure; Hemodynamics; Hormones; Humans; Kinetics; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Random Allocation; Renin | 1987 |
Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade.
Topics: Adult; Angiotensin II; Blood Pressure; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Peptidyl-Dipeptidase A | 1987 |
Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Clinical Trials as Topic; Enalapril; Humans | 1989 |
The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cilazapril; Dose-Response Relationship, Drug; Enalapril; Humans; Peptidyl-Dipeptidase A; Pyridazines; Time Factors; Vascular Resistance | 1989 |
Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions.
Topics: Angiotensin II; Atenolol; Atrial Natriuretic Factor; Double-Blind Method; Drug Therapy, Combination; Enalapril; Factor Analysis, Statistical; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Random Allocation; Renin | 1987 |
Evolution of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Design; Enalapril; Heart Failure; Humans; Hypertension; Renin-Angiotensin System | 1988 |
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Double-Blind Method; Electrolytes; Enalapril; Heart Failure; Humans; Physical Exertion; Potassium; Renin | 1985 |
Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Random Allocation; Renal Circulation; Renin; Time Factors | 1985 |
Controlled trial of enalapril in congestive cardiac failure.
Topics: Angiotensin II; Blood Pressure; Clinical Trials as Topic; Creatinine; Double-Blind Method; Enalapril; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Potassium | 1985 |
Double-blind comparison of captopril and enalapril in mild to moderate hypertension.
Topics: Adult; Angiotensin II; Benzothiadiazines; Blood Pressure; Captopril; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Random Allocation; Renin; Sodium Chloride Symporter Inhibitors | 1986 |
Humoral effects of long-term oral enalapril therapy.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Blood Pressure; Blood Specimen Collection; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Longitudinal Studies; Potassium; Pulse; Random Allocation; Renin; Renin-Angiotensin System | 1986 |
Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Humans; Hypertension; Male; Metoclopramide; Middle Aged; Prolactin; Renin | 1987 |
Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dipeptides; Enalapril; Humans; Hydralazine; Hypertension, Renovascular; Lisinopril; Middle Aged; Prazosin | 1984 |
Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Clinical Trials as Topic; Diet, Sodium-Restricted; Dipeptides; Double-Blind Method; Enalapril; Enalaprilat; Female; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Random Allocation; Renin; Sodium | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Clinical Trials as Topic; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Humans; Male; Peptidyl-Dipeptidase A; Renin | 1981 |
Escape from mineralocorticoid excess: the role of angiotensin II.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Body Weight; Creatinine; Dipeptides; Enalapril; Fludrocortisone; Humans; Male; Natriuresis; Osmolar Concentration; Potassium; Renin | 1982 |
Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Enalapril; Humans; Hypertension; Pulse; Renin | 1982 |
Effects of enalapril on heart rate variability in patients with congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Rate; Humans; Linear Models; Male; Middle Aged | 1995 |
Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Bradykinin; Double-Blind Method; Drug Interactions; Enalapril; Forearm; Heart Rate; Humans; Imidazoles; Losartan; Male; Regional Blood Flow; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilation | 1993 |
Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Topics: Administration, Oral; Adult; Aldosterone; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Humans; Male; Plethysmography; Pyrimidines; Renin; Tetrazoles | 1995 |
Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Double-Blind Method; Electrolytes; Enalapril; Heart Rate; Humans; Male; Pyrimidines; Radioimmunoassay; Renin; Tetrazoles | 1995 |
Combining salicylate and enalapril in patients with coronary artery disease and heart failure.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Coronary Disease; Creatinine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Salicylates; Salicylic Acid | 1995 |
A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Tetrazoles | 1995 |
Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Norepinephrine; Renin; Renin-Angiotensin System; Tetrazoles | 1995 |
Angiotensin converting enzyme inhibition does not affect response to exogenous angiotensin II in the forearm of mild-moderate hypertensive patients.
Topics: Administration, Oral; Adult; Angiotensin II; Blood Flow Velocity; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Receptors, Angiotensin; Vasoconstriction | 1994 |
Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.
Topics: Adolescent; Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Models, Biological; Polycystic Kidney, Autosomal Dominant; Renal Circulation; Renal Plasma Flow, Effective; Renin-Angiotensin System; Sodium, Dietary; Vascular Resistance | 1994 |
Role of the renin-angiotensin system in hypertension in the elderly.
Topics: Adult; Aged; Aging; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Enalapril; Humans; Hypertension; Middle Aged; Prodrugs; Renin; Renin-Angiotensin System; Tetrazoles | 1994 |
Angiotensin converting enzyme inhibition does not affect the response to exogenous angiotensin II in the human forearm.
Topics: Administration, Oral; Adult; Analysis of Variance; Angiotensin II; Blood Pressure; Cross-Over Studies; Double-Blind Method; Enalapril; Forearm; Humans; Plethysmography; Up-Regulation; Vasoconstriction; White People | 1994 |
24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Peptidyl-Dipeptidase A; Renin | 1994 |
Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboons (Papio hamadryas).
Topics: Aldosterone; Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Enalapril; Female; Fetal Death; Fetal Growth Retardation; Papio; Peptidyl-Dipeptidase A; Pregnancy; Pregnancy Outcome; Prospective Studies; Random Allocation; Renin | 1994 |
A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
Topics: Adult; Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Isradipine; Lipoproteins; Male; Middle Aged; Potassium; Sodium | 1993 |
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Enalapril; Female; Humans; Hypertension; Imidazoles; Kidney; Losartan; Male; Middle Aged; Proteinuria; Renal Circulation; Renin-Angiotensin System; Tetrazoles | 1994 |
Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
Topics: Aged; Angiotensin II; Blood Pressure; Captopril; Cardiac Volume; Cause of Death; Double-Blind Method; Drug Tolerance; Enalapril; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Stroke Volume; Survival Rate; Ventricular Function, Left | 1994 |
Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Hemodynamics; Humans; Hypertension; Imidazoles; Male; Middle Aged; Renin | 1993 |
Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Vessels; Bradykinin; Enalapril; Forearm; Humans; Imidazoles; Losartan; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Tetrazoles | 1993 |
Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling.
Topics: Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Dopamine; Double-Blind Method; Enalapril; Epinephrine; Female; Hormones; Humans; Male; Myocardial Infarction; Norepinephrine; Peptidyl-Dipeptidase A; Survival Rate; Sweden; Ventricular Function, Left | 1993 |
Effects of enalapril on ventricular volumes and neurohumoral status after inferior wall myocardial infarction.
Topics: Aged; Aldosterone; Angiotensin II; Cardiac Volume; Double-Blind Method; Enalapril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Ventricular Function, Left | 1993 |
Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Enalapril; Hand; Humans; Imidazoles; Losartan; Male; Reference Values; Renin; Tetrazoles; Vasoconstriction; Veins | 1996 |
Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Synergism; Enalapril; Humans; Imidazoles; Kidney; Losartan; Male; Peptidyl-Dipeptidase A; Regional Blood Flow; Renal Circulation; Renin; Tetrazoles | 1996 |
Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Cough; Diastole; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Systole; Tetrazoles | 1995 |
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril.
Topics: Adult; Age Factors; Aged; Angiotensin II; Antihypertensive Agents; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 1996 |
Additive effects of losartan and enalapril on blood pressure and plasma active renin.
Topics: Adolescent; Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Heart Rate; Humans; Hydrocortisone; Imidazoles; Losartan; Male; Peptidyl-Dipeptidase A; Renin; Tetrazoles; Time Factors | 1997 |
Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cat Diseases; Cats; Dose-Response Relationship, Drug; Enalapril; Female; Hypertension, Renal; Kidney Failure, Chronic; Male; Propranolol; Radioimmunoassay; Renin; Renin-Angiotensin System | 1997 |
Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Single-Blind Method; Tetrazoles | 1997 |
Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Coronary Vessels; Cross-Over Studies; Cyclohexanecarboxylic Acids; Enalapril; Endothelin-1; Humans; Hypertension; Injections, Intra-Arterial; Male; Middle Aged; Myocardium; Neprilysin; Peptides, Cyclic; Protease Inhibitors; Renin; Single-Blind Method; Thiorphan; Vasoconstriction | 1998 |
Angiotensin-converting enzyme gene expression in skeletal muscle in patients with chronic heart failure.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Capillaries; Citrate (si)-Synthase; Enalapril; Endothelium, Vascular; Female; Gene Expression Regulation, Enzymologic; Heart Failure; Humans; Immunohistochemistry; Male; Middle Aged; Muscle, Skeletal; Peptidyl-Dipeptidase A; RNA, Messenger; Transcription Factors | 1998 |
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Exercise Tolerance; Heart Failure; Humans; Losartan; Male; Middle Aged; Muscle, Skeletal; Myosin Heavy Chains | 1998 |
Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Baroreflex; Blood Pressure; Double-Blind Method; Enalapril; Heart Rate; Humans; Losartan; Male; Pressoreceptors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System | 1998 |
Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group.
Topics: Acrylates; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Coronary Circulation; Double-Blind Method; Enalapril; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Thiophenes | 1999 |
Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Topics: Acrylates; Age Factors; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Consumer Product Safety; Cough; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Male; Thiophenes | 1999 |
Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Topics: Acrylates; Adult; Aged; Aged, 80 and over; Aldosterone; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Consumer Product Safety; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Renin; Thiophenes | 1999 |
Effect of eprosartan and enalapril in the treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Topics: Acrylates; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Consumer Product Safety; Cough; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Thiophenes | 1999 |
Renal function and urinary prostanoid excretions in salt-depleted women: comparative effects of enalapril and indomethacin treatments.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chlorides; Cyclooxygenase Inhibitors; Diet, Sodium-Restricted; Dinoprostone; Enalapril; Female; Humans; Indomethacin; Kidney; Kidney Function Tests; Middle Aged; Osmolar Concentration; Prostaglandins; Sodium; Sodium Chloride, Dietary; Thromboxane B2 | 1999 |
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
Topics: Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Vasodilation | 2000 |
The effect of amlodipine and enalapril on blood pressure and neurohumoral activation in hypertensive patients with Ribbing's disease (multiple epiphysal dystrophy).
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Enalapril; Heart Rate; Humans; Hypertension; Norepinephrine; Osteochondrodysplasias | 2000 |
Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Glomerulonephritis, IGA; Hemoglobins; Humans; Isosorbide Dinitrate; Losartan; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Reference Values; Renal Circulation | 2000 |
Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Pilot Projects; Renin-Angiotensin System; Treatment Outcome | 2000 |
Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension: comparison with enalapril. Tasosartan Study Group.
Topics: Analysis of Variance; Angiotensin II; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Pyrimidines; Tetrazoles | 2000 |
The effects of angiotensin-II on lipolysis in humans.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carbohydrate Metabolism; Catecholamines; Enalapril; Energy Metabolism; Humans; Lipid Metabolism; Lipolysis; Male; Oxidation-Reduction; Renin | 2001 |
Effect of angiotensin converting enzyme inhibitor on plasma von Willebrand factor level in patients with coronary artery disease.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Enalapril; Female; Humans; Male; Middle Aged; von Willebrand Factor | 2001 |
Central and peripheral effects of angiotensin II on the cardiovascular response to exercise.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Blood Pressure; Enalapril; Epinephrine; Exercise; Female; Heart Rate; Humans; Male; Norepinephrine; Receptor, Angiotensin, Type 1; Stroke Volume; Tetrazoles; Valine; Valsartan; Vascular Resistance | 2001 |
Radial artery flow-mediated dilatation in heart failure patients: effects of pharmacological and nonpharmacological treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Drug Administration Schedule; Echocardiography, Doppler; Enalapril; Exercise Test; Exercise Therapy; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Radial Artery; Vasodilation | 2001 |
Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta; Blood Pressure; Brachial Artery; Enalapril; Female; Humans; Hyperemia; Male; Middle Aged; Pulse; Reference Values; Renal Dialysis | 2002 |
Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Ultrasonography | 2002 |
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Topics: Administration, Oral; Adult; Aldosterone; Amides; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enalapril; Fumarates; Heart Rate; Humans; Male; Potassium; Renin; Renin-Angiotensin System; Sodium | 2002 |
Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Echocardiography; Enalapril; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Renal Dialysis | 2002 |
[Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Losartan; Middle Aged; Quality of Life; Receptor, Angiotensin, Type 1 | 2002 |
Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enalapril; Humans; Middle Aged; Peptidyl-Dipeptidase A; Renin; Time Factors | 2000 |
Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cell Adhesion Molecules; Chemokine CCL2; Double-Blind Method; E-Selectin; Enalapril; Enzyme Inhibitors; Female; Humans; Hypertension; Intercellular Adhesion Molecule-1; Losartan; Male; Middle Aged; Prospective Studies; Vascular Cell Adhesion Molecule-1 | 2002 |
Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100). Comparison with enalapril.
Topics: Administration, Oral; Amides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Enalapril; Fumarates; Humans; Renin | 2002 |
Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cardiac Output; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Forearm; Heart Failure; Heart Rate; Hemodynamics; Humans; Losartan; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow; Vasodilation | 2004 |
Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Genotype; Heart Failure; Humans; Male; Middle Aged; Neurotransmitter Agents; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renin | 2004 |
Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Enalapril; Endothelium, Vascular; Exercise Tolerance; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Renin-Angiotensin System | 2004 |
Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(1-7) in healthy man.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diet, Sodium-Restricted; Enalapril; Humans; Male; Peptide Fragments; Placebos; Renin-Angiotensin System; Sodium, Dietary | 2005 |
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Double-Blind Method; Drug Therapy, Combination; Enalapril; Exercise Tolerance; Female; Heart Failure; Humans; Irbesartan; Lactic Acid; Male; Middle Aged; Norepinephrine; Prospective Studies; Rest; Tetrazoles | 2005 |
ETa-receptor blockade, but not ACE inhibition, blunts retinal vessel response during isometric exercise.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Double-Blind Method; Enalapril; Endothelin A Receptor Antagonists; Endothelin-1; Exercise Test; Female; Humans; Isometric Contraction; Male; Peptides, Cyclic; Physical Exertion; Placebo Effect; Receptor, Endothelin A; Retinal Vessels; Vasoconstriction | 2006 |
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Proteinuria; Transforming Growth Factor beta | 2006 |
Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
Topics: Adolescent; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Enalapril; Humans; Kidney; Male; Pulsatile Flow; Regional Blood Flow; Renin-Angiotensin System; Sodium; Sodium, Dietary; Vasoconstrictor Agents | 2008 |
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Double-Blind Method; Drug Therapy, Combination; Enalapril; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Peptide Fragments; Radionuclide Angiography; Stroke Volume; Tetrazoles; Treatment Outcome; Ventricular Function, Left | 2009 |
Proteomic Approach to the Potential Role of Angiotensin II in Barrett Dysplasia.
Topics: Adult; Aged; Angiotensin II; Barrett Esophagus; Benzimidazoles; Biopsy; Biphenyl Compounds; Enalapril; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Proteins; Proteomics; Tetrazoles | 2019 |
403 other study(ies) available for angiotensin ii and enalapril
| Article | Year |
|---|---|
The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Bradykinin; Cell Communication; Enalapril; Heart; Imidazoles; In Vitro Techniques; Losartan; Membrane Potentials; Protein Kinase C; Protein Kinases; Rats; Renin-Angiotensin System; Tetrazoles | 1992 |
Endothelium-dependent relaxations are augmented in rats chronically treated with the angiotensin-converting enzyme inhibitor enalapril.
Topics: Acetylcholine; Adenosine Diphosphate; Angiotensin II; Animals; Aorta, Thoracic; Enalapril; Endothelium, Vascular; Male; Molsidomine; Phenylephrine; Rats; Rats, Wistar; Vasoconstriction; Vasodilation; Vasodilator Agents | 1992 |
Increased vascular formation of angiotensin II in one-kidney, one clip hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Blood Vessels; Captopril; Enalapril; Hypertension, Renovascular; In Vitro Techniques; Male; Mesenteric Arteries; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Reference Values; Saralasin | 1992 |
Measurement of converting enzyme activity by antibody-trapping of generated angiotensin II. Comparison with two other methods.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Antibodies, Monoclonal; Antibody Specificity; Enalapril; Humans; Methods; Peptidyl-Dipeptidase A; Radioimmunoassay; Reference Values | 1992 |
Effects of angiotensin II on renal sodium handling and diluting capacity in man pretreated with high-salt diet and enalapril.
Topics: Angiotensin II; Blood Pressure; Dose-Response Relationship, Drug; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Renin; Sodium; Sodium, Dietary | 1992 |
Glomerular hyperfiltration in essential hypertension: hormonal aspects.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Dietary Proteins; Enalapril; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Renal Circulation; Renin | 1992 |
Impact of enalapril therapy on in vitro coronary artery responsiveness in pacing-induced heart failure.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Angiotensin I; Angiotensin II; Animals; Cardiac Pacing, Artificial; Coronary Vessels; Disease Models, Animal; Dogs; Enalapril; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Male; Vasoconstriction | 1992 |
Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Cattle; Cell Movement; Cells, Cultured; Enalapril; Endothelium, Vascular; Gene Expression Regulation, Viral; Lisinopril; Plasminogen Activators; Protein Kinases; Proto-Oncogene Proteins pp60(c-src); Receptors, Angiotensin; RNA, Messenger | 1992 |
Differential effects of enalapril and hydralazine on short-term variability of blood pressure and heart rate in rats.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Drinking Behavior; Enalapril; Heart Rate; Hydralazine; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1992 |
Effects of angiotensin converting enzyme inhibition, sodium depletion, calcium, isoproterenol, and angiotensin II on renin secretion by individual renocortical cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Cell Separation; Enalapril; Hemolytic Plaque Technique; Isoproterenol; Kidney Cortex; Rats; Rats, Wistar; Renin; Sodium | 1992 |
Colocalization and release of angiotensin and renin in renal cortical cells.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Enalapril; Hemolytic Plaque Technique; Immunohistochemistry; Kidney Cortex; Male; Microscopy, Electron; Microscopy, Immunoelectron; Rats; Rats, Inbred WKY; Renin; Tissue Distribution | 1992 |
Hemodynamic effects of central angiotensin I, II, and III in conscious rabbits.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Blood Pressure; Brain; Dose-Response Relationship, Drug; Enalapril; Female; Heart Rate; Hemodynamics; Injections, Intraventricular; Male; Rabbits | 1992 |
Effects, release and disposal of endothelin-1 in conscious dogs.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Dogs; Enalapril; Endothelins; Female; Heart Rate; Potassium; Radioimmunoassay; Sodium; Urea | 1992 |
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Decerebrate State; Enalapril; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Angiotensin; Spinal Cord; Tetrazoles; Thiophenes | 1992 |
Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II.
Topics: Angiotensin II; Animals; Antibodies, Monoclonal; Blood Pressure; Capillary Permeability; Colonic Neoplasms; Enalapril; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude | 1992 |
Effects of angiotensin II and angiotensin converting enzyme inhibitors on contractile and growth responses in isolated carotid arteries of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carotid Arteries; DNA; Enalapril; In Vitro Techniques; Lisinopril; Male; Rats; Rats, Inbred WKY; Vasoconstriction | 1991 |
Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Autoradiography; Edetic Acid; Enalapril; Enzyme Induction; Kidney; Lisinopril; Lung; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Renin; Testis | 1991 |
Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Enalapril; Heart Atria; Heart Ventricles; Indoles; Male; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1991 |
Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Enalapril; Heart Rate; Lisinopril; Male; Rats; Rats, Brattleboro; Saralasin; Water Deprivation | 1990 |
Angiotensin II and left ventricular growth in newborn pig heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Biphenyl Compounds; DNA; Enalapril; Heart Ventricles; Imidazoles; Losartan; Proteins; RNA; Swine; Tetrazoles | 1991 |
Enalapril, an inhibitor of angiotensin converting enzyme, increases the junctional conductance in isolated heart cell pairs.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclic AMP; Enalapril; Heart Conduction System; Heart Ventricles; In Vitro Techniques; Membrane Potentials; Myocardium; Neuromuscular Junction; Propranolol; Protein Kinase Inhibitors; Rats; Renin-Angiotensin System; Vascular Resistance | 1991 |
Role of angiotensin on paracrine prolactin release in the pituitary gland and its possible effects on ovarian function.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Enalapril; Estradiol; Female; Gonadotropin-Releasing Hormone; In Vitro Techniques; Luteinizing Hormone; Male; Microscopy, Phase-Contrast; Ovary; Pituitary Gland; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Saralasin; Swine; Time Factors | 1991 |
Protective effect of ACE- and kininase-inhibitor on the onset of cardiomyopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Cholinesterase Inhibitors; Cricetinae; Enalapril; Mesocricetus; Prostaglandins | 1991 |
Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril.
Topics: Aged; Angiotensin II; Cardiomegaly; Drug Therapy, Combination; Enalapril; Furosemide; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction | 1991 |
Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules.
Topics: Adrenal Glands; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Female; In Vitro Techniques; Lisinopril; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 1991 |
Response of urinary angiotensin to challenges of the renin-angiotensin system.
Topics: Adult; Angiotensin I; Angiotensin II; Captopril; Enalapril; Female; Furosemide; Humans; Immersion; Indomethacin; Male; Renin; Renin-Angiotensin System; Sodium, Dietary | 1991 |
Influence of vasoactive substances on uremic bleeding in rats.
Topics: 4-Aminobenzoic Acid; Angiotensin II; Animals; Bleeding Time; Blood Coagulation; Captopril; Chlorisondamine; Enalapril; Female; Fibronectins; Histamine; Nephrectomy; para-Aminobenzoates; Platelet Aggregation; Rats; Rats, Inbred Strains; Uremia; Ureteral Obstruction; Vasopressins | 1991 |
Absence of a regulatory role of angiotensin II in acute chloride-depletion alkalosis in rats.
Topics: Alkalosis; Angiotensin II; Animals; Blood Pressure; Chlorides; Electrolytes; Enalapril; Male; Rats; Rats, Inbred Strains; Saralasin | 1991 |
A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Enalapril; Humans; Lisinopril; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Time Factors | 1990 |
Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Enalapril; Hypertension; Hypotension; Imidazoles; Immunoglobulin G; Indans; Losartan; Nephrectomy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Renin; Tetrazoles; Time Factors | 1991 |
Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Indans; Male; Mesenteric Arteries; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1991 |
Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Hydralazine; Kidney Glomerulus; Male; Rats; Verapamil | 1990 |
[Effect of chronic enalapril treatment on prorenin, renin and sex hormones during the menstrual cycle in patients with essential hypertension].
Topics: Adult; Angiotensin II; Enalapril; Enzyme Precursors; Female; Gonadal Steroid Hormones; Humans; Hypertension; Menstrual Cycle; Ovulation; Pituitary Gland, Anterior; Renin; Renin-Angiotensin System | 1990 |
The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Gene Expression Regulation; Heart; Hydralazine; Hypertension; Isoquinolines; Kidney; Lisinopril; Male; Quinapril; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrahydroisoquinolines | 1990 |
Abolition of long-term vascular influence of renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Vessels; Electric Stimulation; Enalapril; Lisinopril; Male; Nephrectomy; Neural Conduction; Norepinephrine; Peptidyl-Dipeptidase A; Rabbits; Renin; Renin-Angiotensin System; Sodium; Sympathectomy; Sympathetic Nervous System | 1990 |
Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Cattle; Cells, Cultured; Enalapril; Endothelins; Endothelium, Vascular; Nifedipine; Peptidyl-Dipeptidase A; Pulmonary Artery; Stimulation, Chemical | 1990 |
Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Availability; Blood Pressure; Bradykinin; Captopril; Chemical Phenomena; Chemistry; Enalapril; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Inbred Strains | 1990 |
Angiotensin II regulates renin gene expression.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Blotting, Northern; Enalapril; Gene Expression Regulation; Immunohistochemistry; Kidney; Male; Rats; Rats, Inbred WKY; Renin; RNA, Messenger | 1990 |
Endogenous angiotensin II regulates hepatic angiotensinogen production.
Topics: Angiotensin II; Angiotensinogen; Animals; Enalapril; Liver; Male; Rats; Rats, Inbred Strains; RNA, Messenger; Sodium | 1990 |
Pharmacological evidence for the existence of a local renin-angiotensin system in porcine interlobar renal arteries.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Dinoprost; Enalapril; In Vitro Techniques; Indomethacin; Kallikreins; Kidney; Masoprocol; Muscle Relaxation; Renal Artery; Renin-Angiotensin System; Saralasin; Swine; Tranylcypromine | 1990 |
Angiotensin II control of the renal microcirculation in rats with reduced renal mass.
Topics: Angiotensin II; Animals; Enalapril; Male; Microcirculation; Nephrectomy; Punctures; Rats; Rats, Inbred Strains; Renal Circulation; Time Factors | 1990 |
Role of angiotensin II and vasopressin in cisplatin-induced emesis.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Cisplatin; Dogs; Enalapril; Male; Vomiting | 1990 |
Influence of the renin-angiotensin system on human forearm blood flow.
Topics: Adult; Angiotensin II; Blood Circulation; Decompression; Enalapril; Female; Forearm; Humans; Lower Body Negative Pressure; Male; Renin-Angiotensin System; Saralasin; Vascular Resistance | 1990 |
Acute and subacute prostaglandin and ANG II inhibition on glomerulotubular dynamics in rats.
Topics: Absorption; Angiotensin II; Animals; Blood Pressure; Enalapril; Glomerular Filtration Rate; Hemodynamics; Kidney Glomerulus; Kidney Tubules; Kidney Tubules, Proximal; Loop of Henle; Male; Meclofenamic Acid; Nephrons; Prostaglandin Antagonists; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Depressor mechanism of enalapril in rats made hypertensive by norepinephrine or vasopressin.
Topics: Angiotensin II; Animals; Drug Therapy, Combination; Enalapril; Hypertension; Injections, Intraperitoneal; Male; Norepinephrine; Rats; Rats, Inbred Strains; Vasopressins | 1990 |
Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II.
Topics: Angiotensin II; Angiotensinogen; Animals; Blotting, Northern; Enalapril; Gene Expression Regulation; Genes; Kidney; Liver; Male; Nucleic Acid Hybridization; Phenylephrine; Rats; Rats, Inbred Strains; Reference Values; Renin; Renin-Angiotensin System; Saralasin; Transcription, Genetic | 1990 |
Decreased angiotensin II receptors in subfornical organ of spontaneously hypertensive rats after chronic antihypertensive treatment with enalapril.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Enalapril; Hypertension; Male; Neurosecretory Systems; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Subfornical Organ; Vasomotor System | 1990 |
Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II.
Topics: Aminopeptidases; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Captopril; Carboxypeptidases; Chromatography, High Pressure Liquid; Enalapril; Kidney; Neprilysin; Oligopeptides; Peptide Fragments; Peptides; Rats; Rats, Inbred WKY; Thiorphan | 1990 |
Changes in the pathophysiologic profile of blood pressure determinants during short-term enalapril administration.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Blood Volume; Dose-Response Relationship, Drug; Drug Administration Schedule; Enalapril; Epinephrine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Regional Blood Flow; Renal Circulation; Renin; Sodium; Time Factors | 1986 |
Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
Topics: Administration, Oral; Adult; Angiotensin II; Body Weight; Enalapril; Enalaprilat; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Middle Aged; Natriuresis; Potassium; Renal Circulation; Renin; Sodium; Vasodilation | 1986 |
Conceptual and therapeutic approaches to inhibition of the renin-angiotensin system in chronic heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Enalaprilat; Enzyme Activation; Heart Failure; Heart Rate; Hemodynamics; Humans; Renin-Angiotensin System; Saralasin; Sodium; Vasoconstriction | 1986 |
Converting enzyme inhibitors and brain angiotensin.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Enalaprilat; Kinetics; Male; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1986 |
Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Enalapril; Glomerular Filtration Rate; Heart Rate; Humans; Kidney; Male | 1989 |
Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cerebrovascular Disorders; Enalapril; Glomerular Filtration Rate; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Sodium Chloride | 1989 |
Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Aortic Coarctation; Blood Pressure; Dogs; Enalapril; Extracellular Space; Female; Glomerular Filtration Rate; Hypertension; Male | 1989 |
No effect of short term angiotensin II infusion on plasma renin substrate levels in man.
Topics: Adult; Angiotensin II; Blood Pressure; Cholinesterase Inhibitors; Diuretics; Enalapril; Glucose; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Renin; Renin-Angiotensin System | 1989 |
Prolonged converting enzyme inhibition in non-modulating hypertension.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; p-Aminohippuric Acid; Renal Circulation; Renin; Renin-Angiotensin System; Time Factors | 1989 |
Enalapril decreases angiotensin II receptors in subfornical organ of SHR.
Topics: Acetylcholinesterase; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Brain; Enalapril; Male; Neurosecretory Systems; Organ Specificity; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Reference Values; Renin; Renin-Angiotensin System; Species Specificity; Subfornical Organ | 1989 |
Production of renin, angiotensin II, and aldosterone by adrenal explant cultures: response to potassium and converting enzyme inhibition.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Survival; Culture Techniques; Enalapril; Female; Lisinopril; Potassium; Rats; Rats, Inbred Strains; Renin; Time Factors | 1989 |
Effects of a protein load in patients with early chronic renal failure before and after angiotensin II blockade.
Topics: Adult; Angiotensin II; Blood Pressure; Body Weight; Creatinine; Dietary Proteins; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Urea | 1989 |
Sodium-mediated modulation of aldosterone secretion: impact of converting enzyme inhibition on rat glomerulosa cell response to angiotensin-II.
Topics: Adrenal Medulla; Aldosterone; Angiotensin II; Animals; Blood Pressure; Cells, Cultured; Diet, Sodium-Restricted; Enalapril; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Renin; Sodium | 1989 |
The role of angiotensin-II in progressive diabetic glomerulopathy in the rat.
Topics: Albuminuria; Angiotensin II; Animals; Body Weight; Diabetic Nephropathies; DNA; Dogs; Enalapril; In Vitro Techniques; Kidney; Kidney Glomerulus; Male; Nephrectomy; Organ Size; Proteins; Rats; Rats, Inbred Strains; Reference Values | 1989 |
Effects of angiotensin blockade on the splanchnic circulation in normotensive humans.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output; Enalapril; Epinephrine; Female; Gravitation; Heart Rate; Hemodynamics; Humans; Male; Norepinephrine; Splanchnic Circulation | 1989 |
Effects of inhibitors of the renin-angiotensin system on water intake after insulin administration.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adrenalectomy; Angiotensin II; Animals; Blood Glucose; Captopril; Dose-Response Relationship, Drug; Drinking; Enalapril; Insulin; Nephrectomy; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1989 |
Role of the endogenous angiotensin II in the antihypertensive effect of MK 421 in rats made hypertensive by norepinephrine or vasopressin.
Topics: Angiotensin II; Animals; Blood Pressure; Enalapril; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred Strains; Reference Values; Vasopressins | 1989 |
Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Cardiovascular Physiological Phenomena; Diet, Sodium-Restricted; Enalapril; Female; Humans; Hypertension; Isoproterenol; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Random Allocation; Single-Blind Method; Sodium; Time Factors | 1989 |
Measurement of angiotensin II concentration in rat plasma: pathophysiological applications.
Topics: Analysis of Variance; Anesthesia; Angiotensin II; Angiotensin III; Angiotensins; Animals; Chromatography, High Pressure Liquid; Enalapril; Male; Osmolar Concentration; Pentobarbital; Peptide Fragments; Radioimmunoassay; Rats; Rats, Inbred Strains; Renin | 1989 |
The effect of angiotensin converting enzyme inhibitors on isolated glomeruli.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dinoprostone; Enalapril; Kidney Glomerulus; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1989 |
Effect of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Enalapril; Flow Cytometry; Hypertension; Male; Muscle, Smooth, Vascular; Polyploidy; Rats; Rats, Inbred SHR; Regression Analysis | 1989 |
Humoral effects of ACE-inhibition.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Drug Evaluation; Enalapril; Female; Humans; Hypertension; Male; Norepinephrine; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Time Factors | 1987 |
Effect of a renin-system inhibitor on blood-vessel adaptation in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Vessels; Body Weight; Enalapril; Hematocrit; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Rubidium | 1987 |
Effect of pH on the inhibition of angiotensin converting activity by enalaprilat in the rat perfused mesenteric vascular bed.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Enalapril; Enalaprilat; Hydrogen-Ion Concentration; Kinetics; Male; Mesenteric Arteries; Mesenteric Veins; Perfusion; Rats; Rats, Inbred Strains | 1987 |
Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Diuretics; Dogs; Enalapril; Enalaprilat; Female; Kidney; Methoxamine; Natriuresis; Peptide Fragments; Renin-Angiotensin System; Vascular Resistance | 1988 |
Enalapril attenuates natriuresis of atrial natriuretic factor in humans.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Diuretics; Enalapril; Female; Glomerular Filtration Rate; Humans; Male; Natriuresis; Peptide Fragments; Renal Circulation; Renin-Angiotensin System | 1988 |
The ventrolateral medulla. A new site of action of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cats; Enalapril; Enalaprilat; Heart Rate; Medulla Oblongata; Receptors, Angiotensin; Renin-Angiotensin System | 1988 |
Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination.
Topics: Aldosterone; Angiotensin II; Atenolol; Atrial Natriuretic Factor; Drug Interactions; Drug Therapy, Combination; Enalapril; Heart Rate; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin | 1988 |
Human angiotensin II receptors are regulated by angiotensin II.
Topics: Adult; Angiotensin II; Blood Platelets; Enalapril; Female; Humans; Male; Receptors, Angiotensin; Sodium, Dietary | 1988 |
Role of angiotensin II in experimental membranous nephropathy.
Topics: Angiotensin II; Animals; Antibodies, Monoclonal; Blood Pressure; Disease Models, Animal; Enalapril; Glomerular Filtration Rate; Kidney Tubules, Proximal; Nephritis; Nephrons; Rats; Rats, Inbred Strains; Reference Values; Renin-Angiotensin System | 1988 |
Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Enalapril; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin | 1987 |
In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II.
Topics: Angiotensin I; Angiotensin II; Chromatography, High Pressure Liquid; Enalapril; Humans; Oligopeptides; Radioimmunoassay; Renin | 1988 |
Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats.
Topics: Adaptation, Physiological; Angiotensin I; Angiotensin II; Animals; Dipeptides; Enalapril; Hypoxia; Lisinopril; Lung; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 1988 |
Influence of kinins and angiotensin II on the regulation of papillary blood flow.
Topics: Angiotensin II; Animals; Bicarbonates; Bradykinin; Enalapril; Glomerular Filtration Rate; Glycopeptides; Kidney Cortex; Kidney Medulla; Kinins; Male; Rats; Rats, Inbred Strains; Reference Values; Regional Blood Flow; Saralasin; Sodium; Sodium Bicarbonate | 1988 |
[Ex vivo and in vitro effects of trandolapril on the efflux of 22Na from the caudal artery of the SHR rat. Inhibition of vascular angiotensin II production].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Cell Membrane; Enalapril; Hypertension; Indoles; Male; Ouabain; Rats; Rats, Inbred SHR; Saralasin; Sodium; Sodium Radioisotopes; Tail | 1988 |
[Cocaine and angiotensin ii interactions].
Topics: Angiotensin II; Animals; Antidotes; Cocaine; Diazepam; Enalapril; Enalaprilat; Rats | 1988 |
Angiotensin influences on tubuloglomerular feedback mechanism in hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Enalaprilat; Feedback; Glomerular Filtration Rate; Hypertension, Renovascular; Kidney Glomerulus; Kidney Tubules; Male; Rats; Renal Circulation | 1988 |
Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
Topics: Angiotensin I; Angiotensin II; Animals; Appetite; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dose-Response Relationship, Drug; Drinking; Enalapril; Ramipril; Rats; Rats, Inbred Strains; Renin; Sodium Chloride | 1988 |
Influence of angiotensin II (AII) and angiotensin I (AI) on renal renin synthesis and release.
Topics: Angiotensin I; Angiotensin II; Animals; Enalapril; Female; Kidney; Rats; Rats, Inbred Strains; Renin | 1988 |
Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly.
Topics: Adult; Aged; Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Double-Blind Method; Enalapril; Heart Rate; Humans; Hypertension; Pyridazines; Random Allocation; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1988 |
Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rat.
Topics: Aging; Angiotensin II; Animals; Blood Pressure; Enalapril; Enalaprilat; Kidney Tubules, Proximal; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Water-Electrolyte Balance | 1988 |
Effect of chronic inhibition of angiotensin converting enzyme on baroreceptor reflex in essential hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Humans; Hypertension; Middle Aged; Norepinephrine; Pressoreceptors; Reflex | 1988 |
Changes in the venous compliance by bradykinin and angiotensin II and its significance for the vascular effects of cyclosporine-A.
Topics: Angiotensin II; Animals; Bradykinin; Cyclosporins; Dogs; Enalapril; In Vitro Techniques; Muscle, Smooth, Vascular; Norepinephrine; Saralasin; Serotonin | 1988 |
Tubuloglomerular feedback-dependent influence of angiotensin II on the kidney in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Capillaries; Enalapril; Enalaprilat; Feedback; Glomerular Filtration Rate; Kidney Glomerulus; Kidney Tubules; Male; Rats; Rats, Inbred Strains | 1988 |
Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
Topics: Adrenergic Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Enalapril; Female; Hemodynamics; Hydrochlorothiazide; Male; Nephrectomy; Rats; Rats, Inbred SHR; Renin | 1987 |
Effect of locally generated angiotensin II on noradrenergic neuroeffector function in the rat isolated caudal artery.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Arteries; Enalapril; Enalaprilat; Female; Male; Neurotransmitter Agents; Oligopeptides; Rats; Rats, Inbred Strains; Tail | 1987 |
Interaction of vasopressin, angiotensin and alpha-adrenergic system in sodium depletion in the rat.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Diet, Sodium-Restricted; Enalapril; Male; Phentolamine; Rats; Renal Circulation; Sympathetic Nervous System; Vascular Resistance; Vasopressins | 1987 |
Apparently high plasma angiotensin II levels in patients with essential hypertension treated by converting enzyme inhibition.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dipeptides; Enalapril; Enzyme Inhibitors; Humans; Hypertension; Radioimmunoassay | 1985 |
Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dipeptides; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Renal Circulation; Sodium | 1985 |
[Drugs that block the angiotensin converting enzyme].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Drug Administration Schedule; Enalapril; Humans; Hypertension; Kidney; Kidney Glomerulus | 1985 |
Physiological responses to angiotensin II infusion during chronic angiotensin converting enzyme inhibition in dogs on normal, low and high sodium intake.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diuresis; Dogs; Enalapril; Glomerular Filtration Rate; Potassium; Renal Circulation; Renin; Renin-Angiotensin System; Sodium | 1985 |
Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Chemical Phenomena; Chemistry; Diet, Sodium-Restricted; Dipeptides; Enalapril; Heart Rate; Hydrochlorothiazide; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Inbred SHR | 1985 |
Renal and systemic effects of enalapril in chronic one-kidney hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Dogs; Enalapril; Glomerular Filtration Rate; Hypertension, Renovascular; Kidney; Male; Renal Artery; Renal Artery Obstruction; Renin; Vascular Resistance; Vasopressins; Water-Electrolyte Balance | 1986 |
Hemodynamic effects of enalapril on neonatal chronic partial ureteral obstruction.
Topics: Angiotensin II; Animals; Animals, Newborn; Disease Models, Animal; Enalapril; Glomerular Filtration Rate; Guinea Pigs; Hemodynamics; Hydronephrosis; Kidney Glomerulus; Time Factors; Ureteral Obstruction; Vascular Resistance | 1985 |
Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Dopamine; Dopamine Antagonists; Enalapril; Female; Humans; Hypertension; Male; Metoclopramide; Middle Aged; Peptidyl-Dipeptidase A | 1986 |
The effect of renin-angiotensin system blockade on visceral blood flow during and after thoracic aortic cross-clamping.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arterial Occlusive Diseases; Blood Flow Velocity; Dogs; Enalapril; Enalaprilat; Hemodynamics; Liver Circulation; Pericardium; Renal Circulation; Renin; Renin-Angiotensin System; Saralasin | 1986 |
Centrally administered inhibitors of the generation and action of angiotensin II do not attenuate the increase in ACTH secretion produced by ether stress in rats.
Topics: Adrenocorticotropic Hormone; Angiotensin II; Animals; Captopril; Corticosterone; Corticotropin-Releasing Hormone; Enalapril; Enalaprilat; Male; Peptides; Rats; Renin; Renin-Angiotensin System; Saralasin; Stress, Physiological | 1986 |
Role of the endothelium on the facilitatory effects of angiotensin I and angiotensin II on noradrenergic transmission in the caudal artery of the rat.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensins; Animals; Blood Vessels; Electric Stimulation; Enalapril; Enalaprilat; Endothelium; Female; Male; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Synaptic Transmission; Tail | 1986 |
An improved method for measuring angiotensin I converting enzyme activity using a highly sensitive angiotensin II radioimmunoassay.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Cross Reactions; Edetic Acid; Enalapril; Leucine; Lisinopril; Oligopeptides; Pepstatins; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Radioimmunoassay; Renin; Spectrophotometry; Substrate Specificity | 1985 |
Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Chromatography, High Pressure Liquid; Cross Reactions; Enalapril; Humans; In Vitro Techniques; Male; Radioimmunoassay | 1986 |
Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats.
Topics: Angiotensin II; Angiotensins; Animals; Aorta; Arteries; Enalapril; Hypertension, Renal; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Vasoconstriction | 1986 |
Effects of tetradecapeptide renin substrate on isolated preparations of rat caudal artery, guinea-pig atria and on pithed rat blood pressure.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Decerebrate State; Enalapril; Female; Guinea Pigs; In Vitro Techniques; Male; Norepinephrine; Oligopeptides; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Renin; Saralasin; Synaptic Transmission; Vasoconstriction | 1986 |
Modulation of proximal tubular reabsorption by angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Enalapril; Glomerular Filtration Rate; Kidney Tubules, Proximal; Lithium; Male; Natriuresis; Rats; Renal Circulation | 1986 |
Contribution of endogenous vasoactive compounds to renal vascular resistance in neonatal chronic partial ureteral obstruction.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiac Output; Enalapril; Enalaprilat; Female; Guinea Pigs; Indomethacin; Kidney; Male; Methacrylates; Microspheres; Prostaglandins; Renal Circulation; Strontium Radioisotopes; Thromboxanes; Time Factors; Ureteral Obstruction; Vascular Resistance | 1986 |
Factors affecting renal vein renin ratio in renal artery stenosis. Secretion of inactive renin.
Topics: Angiotensin II; Enalapril; Humans; Hypertension; Hypertension, Renovascular; Kidney; Renal Artery Obstruction; Renal Circulation; Renal Veins; Renin | 1986 |
Response of isolated rat jejunum to angiotensin peptides.
Topics: Adrenalectomy; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensins; Animals; Chlorides; Enalapril; Enalaprilat; Intestinal Absorption; Jejunum; Male; Nephrectomy; Potassium; Prazosin; Rats; Rats, Inbred Strains; Sodium; Water | 1986 |
Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Enalaprilat; Humans; Hypertension; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Renin | 1986 |
Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Hypertension; Indoles; Male; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin-Angiotensin System | 1986 |
Cardiac and vascular actions of decapeptide angiotensin analogs.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Cardiovascular System; Enalapril; Enalaprilat; Male; Myocardial Contraction; Myocardium; Rabbits; Receptors, Angiotensin; Sarcolemma | 1986 |
Effect of angiotensin I converting enzyme inhibition on circulating atrial natriuretic peptide in humans.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Diet, Sodium-Restricted; Enalapril; Female; Humans; Male | 1986 |
Plasma concentrations of angiotensin II and aldosterone during acute left ventricular failure in the dog. Effect of converting enzyme inhibition.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dogs; Enalapril; Enalaprilat; Heart Failure; Hemodynamics | 1986 |
Role of angiotensin II in the hormonal, renal, and electrolyte response to sodium restriction.
Topics: Adrenal Glands; Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diet, Sodium-Restricted; Enalapril; Humans; Male; Middle Aged; Natriuresis; Renin | 1987 |
Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Humans; Hypertension, Renovascular; Kidney Function Tests; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A | 1986 |
Superficial nephron responses to peritubular capillary infusions of angiotensins I and II.
Topics: Angiotensin I; Angiotensin II; Animals; Capillaries; Enalapril; Enalaprilat; Glomerular Filtration Rate; Injections; Kidney Tubules; Male; Nephrons; Rats; Rats, Inbred Strains | 1987 |
De novo intrarenal formation of angiotensin II during control and enhanced renin secretion.
Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Enalapril; Enalaprilat; Female; Kidney; Male; Peptidyl-Dipeptidase A; Renin; Vasoconstriction | 1987 |
Plasma angiotensins and blood pressure during converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Enalapril; Male; Osmolar Concentration; Peptide Fragments; Radioimmunoassay; Rats; Rats, Inbred Strains | 1987 |
Transrenal changes in active and inactive renin and angiotensin II in renal artery stenosis: effects of converting enzyme inhibition.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Middle Aged; Renal Artery Obstruction; Renal Veins; Renin | 1987 |
Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Enalapril; Exercise Test; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1987 |
Angiotensin converting enzyme inhibition reduces ACTH release due to hypoglycaemia.
Topics: Adrenocorticotropic Hormone; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Depression, Chemical; Enalapril; Humans; Hydrocortisone; Hypertension; Male; Middle Aged | 1987 |
The influence of the renin-angiotensin system on adrenergic vasoconstrictor responses in the forearm and splanchnic region in sodium deplete man.
Topics: Angiotensin II; Enalapril; Forearm; Humans; Regional Blood Flow; Renin-Angiotensin System; Saralasin; Sodium; Splanchnic Circulation; Sympathetic Nervous System; Vasoconstriction | 1986 |
The influence of sodium intake on physiological responses to angiotensin II in conscious dogs.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diet, Sodium-Restricted; Dipeptides; Dogs; Enalapril; Natriuresis; Potassium; Renin; Renin-Angiotensin System; Sodium | 1984 |
Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Humans; Hypertension; Kinins; Posture; Potassium; Proline; Prostaglandins; Renin; Renin-Angiotensin System; Sodium | 1984 |
Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin I; Angiotensin II; Blood Pressure; Body Composition; Creatinine; Dipeptides; Drug Evaluation; Enalapril; Female; Heart Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Posture; Potassium; Renal Artery Obstruction; Renin; Sodium | 1984 |
Angiotensin II in adrenergic-induced alterations in glomerular hemodynamics.
Topics: Angiotensin II; Animals; Blood Pressure; Dipeptides; Electric Stimulation; Enalapril; Glomerular Filtration Rate; Kidney; Kidney Glomerulus; Male; Norepinephrine; Rats; Renal Circulation; Saralasin; Sympathetic Nervous System; Vascular Resistance | 1984 |
Renal prostaglandin E in the hypotensive mechanism of MK-421 in conscious rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomechanical Phenomena; Blood Pressure; Consciousness; Dipeptides; Enalapril; Hypertension; Kidney; Male; Norepinephrine; Prostaglandins E; Rats; Rats, Inbred Strains; Sodium; Vasopressins | 1984 |
The role of angiotensin II in the development of hypertension and in the maintenance of glomerular filtration rate during 48 hours of renal artery stenosis in conscious dogs.
Topics: Angiotensin II; Animals; Blood Pressure; Body Water; Dipeptides; Dogs; Enalapril; Glomerular Filtration Rate; Heart Rate; Hypertension, Renal; Male; Renal Artery Obstruction; Renin; Sodium; Time Factors | 1983 |
Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.
Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diet, Sodium-Restricted; Dipeptides; Enalapril; Enzyme Inhibitors; Homeostasis; Kidney; Natriuresis; Potassium; Rats; Renin-Angiotensin System; Sodium; Water-Electrolyte Balance | 1984 |
Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Drug Interactions; Enalapril; Enalaprilat; Humans; Hypertension; Liver; Renin; Time Factors | 1984 |
Angiotensin converting enzyme blockade and thirst.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dipeptides; Drinking; Enalapril; Enalaprilat; Male; Rats; Rats, Inbred WKY; Thirst | 1984 |
Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Electrolytes; Enalapril; Female; Furosemide; Heart Failure; Heart Rate; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Renin; Vascular Resistance | 1983 |
Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Topics: Adrenalectomy; Angiotensin II; Animals; Blood Pressure; Captopril; Dogs; Enalapril; Female; Heart Failure; Heart Ventricles; Hindlimb; Hypertension; Hypertension, Renal; Kidney; Male; Muscles; Rats; Rats, Inbred SHR; Renin; Sodium; Vasoconstriction | 1983 |
The role of the renin-angiotensin system in blood pressure regulation in normotensive animals and man.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Volume; Callithrix; Captopril; Dipodomys; Enalapril; Homeostasis; Humans; Male; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Sodium | 1984 |
Clinical pharmacology of enalapril.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Blood Pressure; Enalapril; Half-Life; Humans; Hypertension; Renin | 1984 |
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".
Topics: Administration, Oral; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dipeptides; Double-Blind Method; Drug Evaluation; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Renin | 1981 |
Enhancement by locally generated angiotensin II of release of the adrenergic transmitter in the isolated rat kidney.
Topics: Angiotensin I; Angiotensin II; Animals; Bradykinin; Dipeptides; Enalapril; Guanethidine; Kidney; Male; Neurotransmitter Agents; Norepinephrine; Pregnenediones; Pressure; Rats; Rats, Inbred Strains; Renin; Serum Albumin, Bovine; Tetrodotoxin | 1983 |
Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dinoprostone; Dipeptides; Electrolytes; Enalapril; Enalaprilat; Heart Rate; Hypertension, Renovascular; Indomethacin; Kallikreins; Male; Prostaglandins E; Rats; Rats, Inbred Strains; Renin | 1984 |
MK 421 and prevention of genetic hypertension development in young spontaneously hypertensive rats.
Topics: Aging; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Dipeptides; Enalapril; Hemodynamics; Hypertension; Male; Norepinephrine; Rats | 1982 |
[Prevention of the development of genetic hypertension by MK 421 in the SHR].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Dipeptides; Enalapril; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred Strains | 1982 |
Aldosterone response to antihypertensive treatment.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Dipeptides; Enalapril; Ethanolamines; Humans; Hypertension; Middle Aged; Prazosin; Pyridazines; Renin; Renin-Angiotensin System; Vasodilator Agents; Verapamil | 1982 |
Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Dipeptides; Enalapril; Enzyme Inhibitors; Female; Humans; Hypertension, Renal; Hypertension, Renovascular; Male; Middle Aged; Renal Artery Obstruction; Renin-Angiotensin System | 1982 |
Modulation of angiotensin II pressor responsiveness by circulating levels of angiotensin II in pregnant sheep.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Female; Pregnancy; Pregnancy, Animal; Sheep | 1983 |
Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensins; Animals; Blood Pressure; Brain; Captopril; Cerebral Ventricles; Dipeptides; Enalapril; Hypertension; Male; Peptidyl-Dipeptidase A; Proline; Rats; Rats, Inbred Strains | 1983 |
Effect of the angiotensin I converting enzyme inhibitor, MK-421, on experimentally induced drinking.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Dehydration; Dipeptides; Dose-Response Relationship, Drug; Drinking; Enalapril; Estrus; Female; Heart Rate; Isoproterenol; Pregnancy; Rats; Rats, Inbred Strains; Saline Solution, Hypertonic | 1982 |
The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Epinephrine; Heart Failure; Hemodynamics; Humans; Norepinephrine; Proline; Renin; Renin-Angiotensin System | 1983 |
Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Physical Exertion; Potassium; Renin; Sodium | 1983 |
Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Diet, Sodium-Restricted; Dipeptides; Enalapril; Female; Humans; Kidney; Male; Middle Aged; p-Aminohippuric Acid; Regional Blood Flow; Renin | 1983 |
Enalapril in the treatment of hypertension with renal artery stenosis.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatinine; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Middle Aged; Potassium; Renin; Sodium; Time Factors; Urea | 1983 |
A possible role for the brain renin-angiotensin system in the regulation of LH secretion.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Dipeptides; Enalapril; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Methohexital; Ovulation; Pregnancy; Proestrus; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Saralasin | 1983 |
Self poisoning with enalapril.
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Dipeptides; Enalapril; Enalaprilat; Female; Humans; Middle Aged; Oxazepam; Peptidyl-Dipeptidase A; Suicide | 1984 |
Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Anion Exchange Resins; Dipeptides; Enalapril; Ethanol; Humans; Indoles; Kidney; Lisinopril; Male; Radioimmunoassay; Rats; Resins, Synthetic | 1984 |
Coronary vascular actions of the converting enzyme inhibitor, enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Captopril; Cats; Coronary Vessels; Dipeptides; Dose-Response Relationship, Drug; Enalapril; In Vitro Techniques; Kinetics; Vasoconstriction | 1984 |
[Reproducibility of acute captopril-induced renal insufficiency with enalapril].
Topics: Acute Kidney Injury; Aged; Angiotensin II; Antihypertensive Agents; Captopril; Dipeptides; Drug Therapy, Combination; Enalapril; Furosemide; Humans; Hypertension, Renovascular; Male; Proline; Renin-Angiotensin System | 1984 |
Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Dogs; Enalapril; Kallikreins; Kinins; Natriuresis; Proline; Propranolol; Renin; Saralasin; Sodium | 1984 |
Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Enalapril; Hypertension; Isoquinolines; Lung; Male; Rabbits; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines; Time Factors | 1995 |
Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tetrazoles | 1995 |
Is estrogen-induced pituitary hyperplasia and hyperprolactinaemia mediated by angiotensin II?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cell Division; Diethylstilbestrol; Enalapril; Enalaprilat; Estrogens; Estrogens, Non-Steroidal; Humans; Hyperpituitarism; Hyperplasia; Hyperprolactinemia; Imidazoles; Losartan; Prolactin; Pyridines; Rats; Rats, Inbred F344; Rats, Wistar; Tetrazoles; Tumor Cells, Cultured | 1995 |
Influence of dopamine and angiotensin II blockade on the acute response to unilateral nephrectomy in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Proteins; Dopamine; Dopamine Antagonists; Enalapril; Haloperidol; Hemodynamics; Kidney Function Tests; Lithium; Male; Natriuresis; Nephrectomy; Potassium; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin-Angiotensin System | 1994 |
Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Desoxycorticosterone; Diet, Sodium-Restricted; Enalapril; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nicardipine; Nitric Oxide; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Vasoconstriction | 1994 |
[The regulation of renin synthesis].
Topics: Angiotensin II; Animals; Enalapril; Kidney; Mice; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Sodium Chloride | 1994 |
Effects of the non-peptide angiotensin II receptor antagonist TCV-116 on systemic and renal hemodynamics in dogs with renal hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Enalapril; Heart Rate; Hemodynamics; Hypertension, Renal; Kidney Function Tests; Male; Renal Circulation; Renin; Tetrazoles | 1995 |
Angiotensin II regulates nephrogenesis and renal vascular development.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Blood Vessels; Enalapril; Kidney; Larva; Nephrons; Rana catesbeiana; Rats; Rats, Sprague-Dawley; Renal Circulation | 1995 |
Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.
Topics: Albuminuria; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Body Weight; Enalapril; Hemodynamics; Hypertension, Renovascular; Imidazoles; Kidney; Losartan; Male; Organ Size; Random Allocation; Rats; Rats, Wistar; Tetrazoles | 1995 |
Furosemide treatment, angiotensin II, and renal growth and development in the rat.
Topics: Analysis of Variance; Angiotensin II; Animals; Drug Evaluation, Preclinical; Enalapril; Furosemide; Kidney; Male; Rats; Rats, Wistar; Regression Analysis; Renin | 1995 |
[Renin synthesis by renal cells during chronic inhibition of angiotensin I converting enzyme].
Topics: Angiotensin I; Angiotensin II; Animals; Enalapril; Female; Kidney; Mice; Renin; Renin-Angiotensin System | 1994 |
Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Enalapril; Extracellular Matrix Proteins; Gene Expression Regulation; Hypertension; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1995 |
Efficacy of intrarenal ACE-inhibition estimated from the renal response to angiotensin I and II in humans.
Topics: Adult; Angiotensin I; Angiotensin II; Enalapril; Female; Humans; Infusions, Intravenous; Kidney; Male; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1995 |
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Dogs; Enalapril; Female; Imidazoles; Injections, Intravenous; Losartan; Macaca mulatta; Male; Nitroglycerin; Pan troglodytes; Pyridines; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Desoxycorticosterone; Disease Models, Animal; Enalapril; Hypertension; Kidney; Male; Rats; Rats, Wistar; Receptors, GABA-A; Renin-Angiotensin System; Sodium Chloride; Tetrazoles | 1995 |
Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits.
Topics: Angiotensin II; Animals; Baroreflex; Biphenyl Compounds; Blood Pressure; Enalapril; Female; Heart Rate; Imidazoles; In Vitro Techniques; Losartan; Male; Rabbits; Tetrazoles | 1995 |
Baroreflex function in streptozotocin (STZ) induced diabetic rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Baroreflex; Blood Pressure; Diabetes Mellitus, Experimental; Enalapril; Heart Rate; Kidney; Male; Rats; Rats, Sprague-Dawley; Reference Values; Sympathetic Nervous System; Vasopressins | 1995 |
Enhanced slow pressor effect of angiotensin II in two-kidney, one clip rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Water; Enalapril; Heart Rate; Hypertension, Renovascular; Male; Natriuresis; Rats; Rats, Sprague-Dawley | 1995 |
Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Enalapril; Extracellular Matrix Proteins; Gene Expression; Hemodynamics; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1994 |
Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II.
Topics: Adult; Angiotensin II; Captopril; Enalapril; Female; Humans; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Middle Aged | 1994 |
Effect of contraceptive steroid and enalapril treatment of systolic blood pressure and plasma renin-angiotensin in the rat.
Topics: Angiotensin II; Animals; Blood Pressure; Contraceptives, Oral; Drug Combinations; Enalapril; Ethinyl Estradiol; Female; Levonorgestrel; Rats; Rats, Sprague-Dawley; Renin; Systole | 1994 |
Myocardial beta-adrenoceptors in pacing-induced heart failure: regulation by enalapril?
Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiac Pacing, Artificial; Dogs; Enalapril; Heart Ventricles; Iodine Radioisotopes; Iodocyanopindolol; Kinetics; Male; Membranes; Myocardium; Norepinephrine; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; Renin | 1994 |
Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Enalapril; Hyperplasia; Hypertrophy; Imidazoles; Immunosuppressive Agents; Juxtaglomerular Apparatus; Losartan; Macaca mulatta; Pyridines; Renin; Tetrazoles; Time Factors | 1994 |
Effect of desalivation on water and sodium chloride intake in rats.
Topics: Angiotensin II; Animals; Dose-Response Relationship, Drug; Drinking; Enalapril; Isoproterenol; Male; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Salivation; Serotonin; Sodium Chloride; Thirst; Water-Electrolyte Balance | 1994 |
The origin of urinary angiotensins in humans.
Topics: Adult; Angiotensin I; Angiotensin II; Enalapril; Female; Humans; Infusions, Intravenous; Kidney; Male; Peptidyl-Dipeptidase A; Radioimmunoassay; Sodium; Sodium, Dietary | 1994 |
Effect of angiotensin II and enalapril on transfer of low-density lipoprotein into aortic intima in rabbits.
Topics: Angiotensin II; Animals; Aorta; Enalapril; Lipoproteins, LDL; Male; Norepinephrine; Rabbits; Tunica Intima | 1994 |
Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Desoxycorticosterone; Enalapril; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Rats; Rats, Wistar; Renin; RNA, Messenger; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta | 1994 |
Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Diet, Sodium-Restricted; Enalapril; Hemodynamics; Imidazoles; Kallikreins; Kidney; Losartan; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin-Angiotensin System; Systole; Tetrazoles | 1994 |
Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Creatinine; Enalapril; Female; Imidazoles; Losartan; Male; Polycystic Kidney Diseases; Rats; Rats, Sprague-Dawley; Renin; Sodium Chloride; Tetrazoles | 1994 |
Converting enzyme inhibition and renal tissue angiotensin II in the rat.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enalapril; Kidney; Male; Radioimmunoassay; Ramipril; Rats; Rats, Sprague-Dawley | 1994 |
Enalapril overdose treated with angiotensin infusion.
Topics: Adult; Angiotensin II; Drug Overdose; Enalapril; Humans; Male | 1993 |
Alpha-adrenergic receptor agonists stimulate ribosome formation in hearts from enalapril-treated piglets.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Animals, Newborn; Enalapril; Heart Ventricles; Muscle Proteins; Myocardium; Prazosin; Receptors, Angiotensin; Ribosomes; Swine | 1993 |
Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Enalapril; Fatty Acids, Unsaturated; Hematocrit; Hydrazines; Hypertension, Pulmonary; Imidazoles; Losartan; Male; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Tetrazoles; Thromboxane A2 | 1994 |
Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Weight; Bradykinin; Doxazosin; Enalapril; Glucose Clamp Technique; Hypertension; Imidazoles; Insulin; Kinins; Losartan; Male; Potassium; Rats; Rats, Inbred SHR; Sodium; Tetrazoles | 1994 |
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Coronary Circulation; Enalapril; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors | 1994 |
Studies on renal function in healthy women with different degrees of induced potassium depletion. 3) Effective roles of prostanoids and angiotensin II in hypokalemic renal dysfunction.
Topics: Angiotensin II; Chlorides; Creatinine; Diuresis; Enalapril; Female; Humans; Hypokalemia; Indomethacin; Kidney; Natriuresis; Potassium; Potassium, Dietary; Prostaglandins; Water | 1993 |
Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Enalapril; Heart; Hemodynamics; Imidazoles; Losartan; Male; Minoxidil; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left | 1993 |
Renal response to amino acid infusion in essential hypertension.
Topics: Adult; Aged; Aldosterone; Amino Acids; Angiotensin II; Blood Pressure; Diastole; Diet, Sodium-Restricted; Enalapril; Female; Glomerular Filtration Rate; Humans; Hypertension; Infusions, Intravenous; Kidney; Male; Middle Aged; Regional Blood Flow; Renin; Sodium; Systole; Urine | 1994 |
Chronic converting enzyme inhibition facilitates baroreceptor resetting to hypertensive levels.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Bradykinin; Captopril; Enalapril; Hypertension; Imidazoles; Losartan; Male; Pressoreceptors; Rats; Rats, Wistar; Reference Values; Regression Analysis; Tetrazoles | 1994 |
Effect of angiotensin II blockade on dietary protein-induced renal growth.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Dietary Proteins; Enalapril; Hypertrophy; Imidazoles; Kidney; Losartan; Male; Organ Size; Rats; Rats, Sprague-Dawley; Tetrazoles | 1993 |
Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitors.
Topics: Acrylates; Acute Kidney Injury; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cough; Dogs; Enalapril; Female; Glomerular Filtration Rate; Imidazoles; Male; Renal Circulation; Thiophenes | 1993 |
Discrepancy between renin mRNA and plasma renin level in angiotensin-converting enzyme inhibitor-treated rats.
Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Enalapril; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger | 1993 |
In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles; Triazoles | 1993 |
The role of the renin-angiotensin system in insulin sensitivity in normotensive subjects.
Topics: Adult; Angiotensin II; Catecholamines; Drug Resistance; Enalapril; Glucose; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Male; Potassium; Renin-Angiotensin System | 1993 |
The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Topics: Angiotensin II; Animals; Aorta; Arteriovenous Shunt, Surgical; Biphenyl Compounds; Body Weight; Cardiac Volume; Cardiomegaly; Enalapril; Hemodynamics; Imidazoles; Losartan; Male; Myocardium; Organ Size; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Venae Cavae | 1993 |
Osmotic stimuli attenuate vasoactive intestinal peptide gene expression in the rat anterior pituitary gland.
Topics: Angiotensin II; Animals; Dehydration; Enalapril; Gene Expression Regulation; Male; Osmotic Pressure; Pituitary Gland, Anterior; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride; Vasoactive Intestinal Peptide; Water-Electrolyte Balance | 1993 |
In vivo stimulation of aldosterone biosynthesis by endothelin: loci of action and effects of doses and infusion rate.
Topics: Aldosterone; Angiotensin II; Animals; Cytosol; Dose-Response Relationship, Drug; Enalapril; Endothelins; Male; Mitochondria; Rats; Zona Glomerulosa | 1993 |
Angiotensin converting enzyme inhibition of the gonadotropin-stimulated rabbit: effect on estradiol production.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Estradiol; Female; Gonadotropins; Ovarian Hyperstimulation Syndrome; Prospective Studies; Rabbits; Radioimmunoassay; Random Allocation | 1995 |
Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Hypertrophy, Left Ventricular; Isoquinolines; Male; Myocardium; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Pressure | 1995 |
Enalapril overdose and the corrective effect of intravenous angiotensin II.
Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anuria; Drug Overdose; Enalapril; Female; Humans; Hypotension; Infusions, Intravenous; Middle Aged | 1995 |
Impact of cyclo-oxygenase blockade on juxtamedullary microvascular responses to angiotensin II in rat kidney.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Cyclooxygenase Inhibitors; Enalapril; Erythrocytes; Glomerular Filtration Rate; In Vitro Techniques; Juxtaglomerular Apparatus; Kidney Medulla; Male; Nephrons; Piroxicam; Rats; Rats, Sprague-Dawley; Renal Circulation; Statistics as Topic; Vasoconstrictor Agents | 1995 |
Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine Vasopressin; Biphenyl Compounds; Blood Pressure; Cerebral Ventricles; Corticosterone; Enalapril; Ergolines; Fenfluramine; Heart Rate; Imidazoles; Injections, Intraventricular; Losartan; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Renin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Tetrazoles | 1996 |
Renin-angiotensin system and cell communication in the failing heart.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Cells, Cultured; Cricetinae; Enalapril; Gap Junctions; Heart Conduction System; Heart Failure; Imidazoles; Losartan; Male; Membrane Potentials; Mesocricetus; Patch-Clamp Techniques; Renin-Angiotensin System; Tetrazoles | 1996 |
Role of ANG II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Enalapril; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reference Values; Tetrazoles; Time Factors | 1996 |
Role of aldosterone in the remnant kidney model in the rat.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Disease Models, Animal; Enalapril; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Mineralocorticoid Receptor Antagonists; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Spironolactone; Tetrazoles | 1996 |
Role of angiotensin II in reflex tachycardia during hypotension caused by a calcium channel blocker.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Enalapril; Hemodynamics; Hypotension; Nitrobenzenes; Piperazines; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex; Tachycardia; Tachycardia, Sinus; Telemetry; Tetrazoles; Time Factors | 1996 |
Influence of vascular tone on vasoconstrictor responses to the 5-HT 1-like receptor agonist sumatriptan in anaesthetised rabbits.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Chlorisondamine; Drug Synergism; Enalapril; Ganglionic Blockers; Heart Rate; Male; Methiothepin; Muscle, Smooth, Vascular; Rabbits; Regional Blood Flow; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 1996 |
Respective role of humoral factors and blood pressure in aortic remodeling of DOCA hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Benzimidazoles; Blood Pressure; Bosentan; Calcium Channel Blockers; Desoxycorticosterone; Enalapril; Endothelin Receptor Antagonists; Endothelins; Hypertension, Renovascular; Male; Mibefradil; Rats; Rats, Wistar; Sulfonamides; Tetrahydronaphthalenes; Tunica Media | 1996 |
Cyclical changes in the renin-angiotensin-aldosterone system during the menstrual cycle of the baboon (Papio hamadryas).
Topics: Aldosterone; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Electrolytes; Enalapril; Female; Lactation; Male; Menstrual Cycle; Papio; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System | 1996 |
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Diseases; Dogs; Echocardiography; Enalapril; Female; Furosemide; Heart Failure; Heart Rate; Hydralazine; Male; Mitral Valve Insufficiency; Renin-Angiotensin System; Vasodilator Agents; Water-Electrolyte Balance | 1996 |
Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice.
Topics: Administration, Oral; Analgesics; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Brain; Enalapril; Imidazoles; Indoles; Losartan; Male; Mice; Naloxone; Pain Measurement; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Tetrazoles | 1996 |
Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect?
Topics: Acute Disease; Albuminuria; Aminopeptidases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Enalapril; Glutamyl Aminopeptidase; Histocytochemistry; Imidazoles; In Situ Hybridization; Losartan; Mice; Mice, Inbred BALB C; Tetrazoles | 1996 |
Role of the renin-angiotensin system on cardiac diseases.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Electrocardiography; Enalapril; Heart Conduction System; Heart Diseases; Humans; Renin; Renin-Angiotensin System | 1996 |
Inhibition of angiotensin-converting enzyme modulates structural and functional adaptation to loop diuretic-induced diuresis.
Topics: Aldosterone; Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Consciousness; Diuresis; Diuretics; Electrolytes; Enalapril; Hematocrit; Kidney Cortex; Kidney Function Tests; Kidney Tubules; Male; Rats; Rats, Wistar; Rubidium; Sodium; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Torsemide; Urine; Vasoconstrictor Agents; Water-Electrolyte Balance | 1997 |
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cytokines; Enalapril; Fibrin; Fibrinolysin; Fibrosis; Gene Expression Regulation, Enzymologic; Growth Substances; Imidazoles; In Situ Hybridization; Kidney; Male; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Tetrazoles; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 1997 |
The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriosclerosis; Cell Division; Cholesterol; Cholesterol, Dietary; Chromatography, High Pressure Liquid; Enalapril; Imidazoles; Lipoproteins; Oligonucleotide Probes; Polymerase Chain Reaction; Pyridines; Rabbits; Random Allocation; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Spectrophotometry | 1996 |
Cigarette smoke increases gastric ulcer size in part by an angiotensin II-mediated mechanism in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Immunoblotting; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Smoking; Somatomedins; Stomach Ulcer; Transforming Growth Factor beta | 1997 |
Distribution of Fos-immunoreactivity in rat brain following a dipsogenic dose of captopril and effects of angiotensin receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain Chemistry; Captopril; Drinking; Enalapril; Hypothalamus; Immunohistochemistry; Male; Naphthyridines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 1997 |
Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Enalapril; Endothelium, Vascular; Imidazoles; Losartan; Male; Pyridines; Rabbits; Receptors, Angiotensin; Tetrazoles | 1996 |
PGE2 production after angiotensin-converting enzyme inhibition.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Captopril; Dinoprostone; Enalapril; Female; Humans; Immune Tolerance; In Vitro Techniques; Indomethacin; Lymphocyte Activation; Male; Muromonab-CD3; T-Lymphocytes | 1997 |
Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriosclerosis; Blood Pressure; Cholesterol, Dietary; Enalapril; Male; Peptidyl-Dipeptidase A; Rabbits | 1997 |
Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Enalapril; Hexamethonium; Imidazoles; Kidney; Losartan; Mice; Mice, Knockout; Phentolamine; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; RNA, Messenger; Sympatholytics; Tetrazoles; Time Factors; Transcription, Genetic | 1997 |
Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Disease Models, Animal; Enalapril; Glucose; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred Strains; Tetrazoles; Verapamil | 1997 |
Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Dogs; Enalapril; Heart Rate; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Tetrazoles; Valine; Valsartan | 1997 |
Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Circulation; Blood Pressure; Bradykinin; Cardiac Output; Dogs; Enalapril; Female; Heart Rate; Hemodynamics; Male; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Tetrazoles; Valine; Valsartan; Vascular Resistance | 1997 |
Angiotensin I modulates Ca-transport systems in the rat heart through angiotensin II.
Topics: Actins; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Blotting, Northern; Calcium; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Enalapril; Heart; In Situ Hybridization; Isradipine; Male; Myocardium; Rats; Rats, Wistar; Receptors, Angiotensin; Sodium-Potassium-Exchanging ATPase | 1997 |
Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diet, Sodium-Restricted; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Renal Circulation; Renin; Renin-Angiotensin System | 1997 |
ANG II prolongs splanchnic nerve-mediated inhibition of duodenal mucosal alkaline secretion in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bicarbonates; Biphenyl Compounds; Duodenum; Electric Stimulation; Enalapril; Hydrogen-Ion Concentration; Imidazoles; In Vitro Techniques; Intestinal Mucosa; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Splanchnic Nerves; Tetrazoles; Time Factors | 1997 |
Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Enalapril; Heart Rate; Hypertension, Renovascular; Injections, Intraventricular; Male; Peptide Fragments; Pressoreceptors; Rats; Rats, Wistar; Reflex | 1997 |
Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Body Weight; Clusterin; Enalapril; Epidermal Growth Factor; Glycoproteins; Growth Substances; Kidney; Kidney Glomerulus; Kidney Tubules; Molecular Chaperones; Organ Size; Protein Precursors; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 1997 |
Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
Topics: Aging; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Enalapril; Gene Expression Regulation, Developmental; Heart; Hepatocyte Growth Factor; Humans; Hypertension; Imidazoles; Losartan; Lung; Male; Myocardium; Organ Specificity; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regression Analysis | 1997 |
Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Progression; Enalapril; Fibrosis; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Kidney Failure, Chronic; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Tetrazoles; Transforming Growth Factor beta | 1997 |
High-protein diets augment albuminuria in rats with Heymann nephritis by angiotensin II-dependent and -independent mechanisms.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Dietary Proteins; Enalapril; Glomerular Filtration Rate; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1998 |
Characterization of ventricular myocytes from the newborn pig heart.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Cell Division; Cells, Cultured; Enalapril; Endothelins; Heart Ventricles; Myocardium; Norepinephrine; Phenylalanine; Propranolol; Protein Biosynthesis; RNA, Transfer, Phe; Swine; Ventricular Function | 1998 |
Angiotensin II receptor antagonists: what future?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Enalapril; Humans; Hypertension; Losartan | 1998 |
The reduction in alcohol intake in rats by isoproterenol is attenuated by indomethacin but not enalapril: relationship to blood glucose levels.
Topics: Adrenergic beta-Agonists; Alcohol Drinking; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Drinking; Enalapril; Ethanol; Hyperglycemia; Indomethacin; Isoproterenol; Male; Rats; Rats, Wistar | 1998 |
Nitric oxide release as an essential mitigating step in tubuloglomerular feedback: observations during intrarenal nitric oxide clamp.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Feedback; Glomerular Filtration Rate; Kidney Glomerulus; Kidney Tubules; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pressoreceptors; Rats; Rats, Sprague-Dawley; Reference Values; Renal Circulation | 1998 |
Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diet, Sodium-Restricted; Enalapril; Glomerular Filtration Rate; Hypertension, Renovascular; Kidney; Kinins; Losartan; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium | 1998 |
Antihypertensive activity and pharmacokinetics of KD3-671, a nonpeptide AT1-receptor antagonist, in renal hypertensive dogs.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Dogs; Enalapril; Hypertension, Renal; Imidazoles; Male; Renin; Tetrazoles | 1998 |
Urinary acidification and net acid excretion in adult rats treated neonatally with enalapril.
Topics: Age Factors; Ammonium Chloride; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Bicarbonates; Drinking; Enalapril; Glomerular Filtration Rate; Hydrogen-Ion Concentration; Kidney; Male; Organ Size; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Sulfates; Urine | 1998 |
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Eating; Enalapril; Fibronectins; Fibrosis; Glomerulonephritis, Membranoproliferative; Kidney; Losartan; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 1998 |
Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia.
Topics: Acidosis; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Citric Acid; Enalapril; Female; Humans; Hypokalemia; Male; Rats; Rats, Sprague-Dawley | 1998 |
Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Heart Ventricles; Isoquinolines; Male; Myocardial Infarction; Myocardium; Nephrectomy; Quinapril; Rats; Rats, Wistar; Renin; Tetrahydroisoquinolines | 1999 |
The involvement of the renin-angiotensin system in the regulation of cell proliferation in the rat endometrium.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; DNA Replication; Enalapril; Endometrium; Estradiol; Female; Losartan; Ovariectomy; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 1999 |
Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitor.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autoradiography; Colonic Neoplasms; Enalapril; Extravasation of Diagnostic and Therapeutic Materials; Female; Mice; Mice, Inbred BALB C; Mice, Nude; Radioimmunotherapy; Serum Albumin; Thallium Radioisotopes; Tissue Distribution; Transplantation, Heterologous | 1998 |
The pathogenetic role of endogenous angiotensin II in stress ulcer in obstructive jaundice rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cholestasis; Enalapril; Male; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological | 1998 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Intrarenal angiotensin converting enzyme inhibition in spontaneously hypertensive rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Enalapril; Heart Rate; Hypertension; Infusion Pumps; Kidney; Kidney Medulla; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Species Specificity | 1999 |
Targeting TGF-beta overexpression: maximizing the antifibrotic actions of angiotensin II blockade in anti-Thy1 glomerulonephritis.
Topics: Angiotensin II; Animals; Enalapril; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Thy-1 Antigens; Transforming Growth Factor beta | 1999 |
Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Enalapril; Hydrostatic Pressure; Kidney Medulla; Laser-Doppler Flowmetry; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation | 1999 |
Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium.
Topics: Adenosine Triphosphate; Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Heart Rate; In Vitro Techniques; Ligation; Male; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Telmisartan; Time Factors; Ventricular Pressure | 1999 |
Hypertension and renal injury in experimental polycystic kidney disease.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Enalapril; Fibrosis; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; Polycystic Kidney, Autosomal Dominant; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Vasoconstrictor Agents | 1999 |
[Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Doxorubicin; Eicosanoids; Enalapril; F2-Isoprostanes; Losartan; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Wistar | 1999 |
Volume expansion natriuresis during servo control of systemic blood pressure in conscious dogs.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Blood Proteins; Diuresis; Dogs; Electrolytes; Enalapril; Female; Hemodynamics; Kidney; Natriuresis; Nitroprusside; Osmolar Concentration; Plasma Substitutes; Vasodilator Agents | 2000 |
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Fosinopril; Heart Failure; Humans; Lisinopril; Male; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Treatment Failure; Valine; Valsartan | 2000 |
Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Azoles; Biphenyl Compounds; Blood Pressure; Enalapril; Heart Rate; Hypertension, Renovascular; Male; Mesenteric Arteries; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Splanchnic Circulation; Vasoconstriction | 2000 |
Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor- inhibition on transcapillary glucose transport in humans.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Bradykinin; Capillaries; Enalapril; Glucose; Humans; Hyperinsulinism; Losartan; Male; Receptors, Angiotensin | 2000 |
Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diet, Protein-Restricted; Enalapril; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Transforming Growth Factor beta; Treatment Outcome | 2000 |
Mechanism of reduced GFR in rabbits with ischemic acute renal failure.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Creatinine; Enalapril; Female; Glomerular Filtration Rate; Ischemia; Kidney; Kidney Tubules; Losartan; Male; Rabbits; Renal Circulation; Urodynamics | 2000 |
Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Cell Division; Enalapril; Hypertension; Losartan; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Receptors, Angiotensin | 2000 |
Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
Topics: Adolescent; Adrenal Glands; Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diet, Sodium-Restricted; Enalapril; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Reference Values; Renal Artery; Renal Plasma Flow; Renal Veins; Vasoconstriction | 2000 |
Regional renal haemodynamics of angiotensin II infusion under prostaglandin, kinin or converting enzyme inhibition in the Wistar rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Bradykinin; Enalapril; Hemodynamics; Ketoprofen; Kidney Medulla; Losartan; Male; Nitric Oxide; Prostaglandin Antagonists; Rats; Rats, Wistar; Renal Circulation | 2000 |
Contribution of angiotensin II to late renal injury after acute ischemia.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Enalapril; Ischemia; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors | 2000 |
Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Echocardiography; Enalapril; Female; Heart Failure; Hypertension, Renal; Imidazoles; Muscle Fibers, Skeletal; Myocardium; Organ Size; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrazoles; Ventricular Remodeling | 2000 |
Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Basilar Artery; Blood Pressure; Brain; Enalapril; Enzyme Inhibitors; Hypertension; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Function, Left | 2000 |
Pharmacologic intervention with angiotensin II and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Enalapril; Female; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Radioimmunotherapy; Radionuclide Imaging; Radiotherapy Dosage; Vasoconstrictor Agents | 2000 |
Zinc deficiency further increases the enhanced expression of endothelin-1 in glomeruli of the obstructed kidney.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Copper; Enalapril; Endothelin-1; Endothelins; Female; Gene Expression; Immunohistochemistry; In Situ Hybridization; Kidney Glomerulus; Peptidyl-Dipeptidase A; Protein Precursors; Rats; Rats, Sprague-Dawley; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Diseases; Ureteral Obstruction; Zinc | 2000 |
Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Circadian Rhythm; Drug Interactions; Enalapril; Fibrinolysis; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2000 |
Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Enalapril; Enzyme Activation; Hypertension, Renal; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Artery; Surgical Instruments; Tetrazoles; Vasoconstrictor Agents | 1996 |
Renin-angiotensin system inhibitors as antihypertrophic agents.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kidney; Kidney Diseases; Losartan; Nephrectomy; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2000 |
Effect of angiotensin II blockade on renal injury in mineralocorticoid-salt hypertension.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Disease Models, Animal; Enalapril; Hypertension, Renal; Kidney; Kidney Function Tests; Losartan; Male; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Renal Insufficiency; Sodium Chloride | 2000 |
Angiotensin-converting enzyme inhibitor prevents age-related endothelial dysfunction.
Topics: Acetylcholine; Administration, Oral; Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Biological Factors; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Heart Rate; Hydralazine; Hydrochlorothiazide; In Vitro Techniques; Male; Mesenteric Arteries; Nitric Oxide Synthase; Norepinephrine; Rats; Rats, Inbred WKY; Vasodilation | 2000 |
Involvement of angiotensin II and endothelin-1 in the development of submandibular gland hypertrophy in response to isoproterenol in rats.
Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Dobutamine; Enalapril; Endothelin-1; Hypertrophy; Isoproterenol; Male; Rats; Rats, Wistar; Submandibular Gland | 2000 |
New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Enalapril; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Losartan; Male; Premedication; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Heterotopic | 2000 |
In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Disease Models, Animal; Enalapril; ErbB Receptors; Hypertension; Infusions, Intravenous; Male; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Perindopril; Phosphorylation; Rats; Rats, Inbred SHR; Receptors, Platelet-Derived Growth Factor | 2000 |
Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Humans; Losartan; Proteinuria | 2000 |
Effect of chronic angiotensin II inhibition on the cardiovascular system of the normal rat.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Body Weight; Cardiovascular System; Collagen; Cyclic GMP; DNA; Drinking; Enalapril; Fibrosis; Losartan; Male; Myocardium; NADPH Dehydrogenase; Rats; Rats, Wistar; Reference Values; Systole; Time Factors | 2000 |
Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Disease Models, Animal; Enalapril; Enzyme Precursors; Female; Ganglionic Blockers; Gene Dosage; Hexamethonium; Histamine; Hypertension; Nephrectomy; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Renin; Vasoconstrictor Agents | 2001 |
Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Arterioles; Blood Pressure; Enalapril; Endothelium, Vascular; Kidney Medulla; Laser-Doppler Flowmetry; Male; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Renal Artery | 2001 |
Modulation of the renin-angiotensin system may alter the adrenocortical regeneration.
Topics: Adrenal Cortex; Adrenalectomy; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cell Division; Enalapril; Losartan; Male; Mitosis; Nifedipine; Rats; Rats, Wistar; Regeneration; Renin; Renin-Angiotensin System; Steroids | 2001 |
Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis.
Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antigens, CD; Collagen; Enalapril; Enzyme-Linked Immunosorbent Assay; Fibrosis; Kidney; Lymphotoxin-alpha; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron; Muscle, Smooth; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; RNA, Messenger; Tumor Necrosis Factor-alpha; Ureteral Obstruction | 2001 |
Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar fatty rats).
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Disease Progression; Enalapril; Glomerular Mesangium; Male; Proteins; Proteinuria; Rats; Rats, Wistar; Rats, Zucker; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Triglycerides | 2001 |
Antihypertensive drugs induce structural remodeling of the penile vasculature.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Enalapril; Hydralazine; Male; Methoxamine; Penis; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins; Ventricular Remodeling | 2001 |
[Bilateral renal artery stenosis--a cause of acute pulmonary edema].
Topics: Acute Kidney Injury; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diagnosis, Differential; Enalapril; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Male; Pulmonary Edema; Renal Artery Obstruction | 2001 |
Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Enalapril; Losartan; Male; NADPH Dehydrogenase; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Wistar; Reference Values; Time Factors | 2001 |
Chronic angiotensin converting enzyme inhibition enhances renal vascular responsiveness to acetylcholine in anaesthetized rabbits.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Enalapril; Kidney; Rabbits; Renal Artery; Renal Circulation; Time Factors; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
[Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anticholesteremic Agents; Antihypertensive Agents; Azathioprine; Captopril; Cholesterol; Creatinine; Cyclophosphamide; Data Interpretation, Statistical; Enalapril; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Lovastatin; Male; Nephrotic Syndrome; Prednisolone; Retrospective Studies; Tetrazoles; Time Factors; Valine; Valsartan | 2001 |
Effect of angiotensin II synthesis blockade on the hypertensive response to chronic reductions in uterine perfusion pressure in pregnant rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Blood Pressure; Body Weight; Enalapril; Female; Hypertension; Pregnancy; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Uterus | 2001 |
Splanchnic blood flow and hepatic glucose production in exercising humans: role of renin-angiotensin system.
Topics: Adrenocorticotropic Hormone; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; C-Peptide; Cross-Over Studies; Enalapril; Exercise; Fatty Acids, Nonesterified; Glucagon; Hemodynamics; Human Growth Hormone; Humans; Insulin; Liver; Male; Oxygen Consumption; Reference Values; Regional Blood Flow; Renin-Angiotensin System; Splanchnic Circulation; Tilt-Table Test | 2001 |
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Dogs; Electrophysiology; Enalapril; Endomyocardial Fibrosis; Heart Atria; Heart Failure; Hemodynamics; Hydralazine; Isosorbide Dinitrate; Mitogen-Activated Protein Kinases; Renin-Angiotensin System; Signal Transduction; Tachycardia, Ventricular | 2001 |
The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4.
Topics: Alanine Transaminase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Cells, Cultured; Enalapril; Fibrosis; Immunohistochemistry; Liver; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System | 2001 |
Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Volume; Enalapril; Extracellular Space; Infusions, Intra-Arterial; Kidney; Microdialysis; Rats; Rats, Sprague-Dawley; Thiopental | 2002 |
Effects of long-term enalapril and losartan therapy of hypertension on cardiovascular aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Drug Administration Schedule; Enalapril; Hypertension; Losartan; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; Reference Values | 2001 |
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bradykinin; Creatinine; Enalapril; Kidney; Losartan; Male; Nephrectomy; Nifedipine; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Vasodilator Agents | 2002 |
Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Enalapril; F2-Isoprostanes; Losartan; Nephrotic Syndrome; Rats | 2002 |
Suppression of endotoxin-induced renal tumor necrosis factor-alpha and interleukin-6 mRNA by renin-angiotensin system inhibitors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Cytokines; Enalapril; Endotoxins; Gene Expression Regulation; Interleukin-6; Kidney; Lipopolysaccharides; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Tumor Necrosis Factor-alpha | 2002 |
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
Topics: Administration, Oral; Allopurinol; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Benzofurans; Blood Pressure; Diuretics; Enalapril; Hydrochlorothiazide; Hypertension; Kidney; Losartan; Male; Muscle, Smooth, Vascular; Oxonic Acid; Rats; Rats, Sprague-Dawley; Sodium Chloride Symporter Inhibitors; Sodium Chloride, Dietary; Uric Acid; Uricosuric Agents; Vascular Diseases | 2002 |
Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Cardiomegaly; Cardiovascular System; Chronic Disease; Enalapril; Losartan; Male; Mesenteric Arteries; Myocardial Infarction; Rats; Rats, Wistar | 2002 |
Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cyclosporine; Disease Models, Animal; Enalapril; Endothelial Growth Factors; Extracellular Matrix Proteins; Gene Expression; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Kidney Diseases; Losartan; Lymphokines; Male; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2002 |
Upregulation of vasopressin V2 and aquaporin 2 in the inner medullary collecting duct of cardiomyopathic hamsters is attenuated by enalapril treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Cardiomyopathies; Cricetinae; Cyclic AMP; Enalapril; Gene Expression; Kidney Medulla; Kidney Tubules, Collecting; Male; Receptors, Vasopressin; RNA, Messenger; Up-Regulation | 2002 |
Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Apoptosis; bcl-X Protein; Clusterin; Enalapril; Female; Glycoproteins; Heart; Hydralazine; In Situ Nick-End Labeling; Molecular Chaperones; Myocardium; Pregnancy; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Renin | 2002 |
Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema.
Topics: Adult; Angioedema; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cough; Diabetes Mellitus, Type 1; Enalapril; Female; Humans; Losartan; Pharyngitis | 2002 |
ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Female; Fibrosis; Gene Expression; Kidney; Mice; Mice, Inbred C57BL; Nitric Oxide; Receptor, Endothelin B; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ureteral Obstruction | 2003 |
Long-term angiotensin II inhibition increases mitochondrial nitric oxide synthase and not antioxidant enzyme activities in rat heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Catalase; Enalapril; Glutathione Peroxidase; Hydrogen Peroxide; Losartan; Male; Mitochondria, Heart; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oxidoreductases; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors | 2002 |
Renal function and angiotensin AT1 receptor expression in young rats following intrauterine exposure to a maternal low-protein diet.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diet, Protein-Restricted; Enalapril; Female; Glomerular Filtration Rate; Hypertension; Kidney; Kidney Glomerulus; Male; Maternal Nutritional Physiological Phenomena; Models, Animal; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin | 2003 |
Effect of blockade of endogenous angiotensin II on baroreflex function in conscious diabetic rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Consciousness; Diabetes Mellitus, Experimental; Enalapril; Heart Rate; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 2003 |
Role of angiotensin in body fluid homeostasis of mice: fluid intake, plasma hormones, and brain Fos.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Animals; Behavior, Animal; Body Fluids; Body Water; Brain Chemistry; Drinking; Enalapril; Female; Furosemide; Hematocrit; Homeostasis; Hormones; Male; Mice; Mice, Inbred Strains; Polyethylene Glycols; Proto-Oncogene Proteins c-fos; Renin; Sodium Chloride; Subfornical Organ; Water-Electrolyte Balance | 2003 |
Angiotensins in plasma of hypertensive rats and human.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chromatography, High Pressure Liquid; Disease Models, Animal; Enalapril; Humans; Hypertension; Male; Middle Aged; Radioimmunoassay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Rats, Wistar | 2003 |
Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.
Topics: Adolescent; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Circadian Rhythm; Diabetes Mellitus, Type 1; Enalapril; Glomerular Filtration Rate; Glucose Clamp Technique; Hemodynamics; Humans; Renal Circulation; Renin-Angiotensin System; Vascular Resistance | 2003 |
Control of arterial pressure by angiotensin II and nitric oxide at the onset of diabetes.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Enalapril; Hypertension; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2003 |
Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II.
Topics: Angiotensin II; Animals; Cell Communication; Cricetinae; Dose-Response Relationship, Drug; Enalapril; Enalaprilat; Losartan; Male; Mesocricetus; Myocardium; Patch-Clamp Techniques; Peptides; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System; Temperature; Time Factors | 2003 |
Does whole body autoregulation mediate the hemodynamic responses to increased dietary salt in rats with clamped ANG II?
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Enalapril; Homeostasis; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium Chloride, Dietary; Vascular Resistance; Vasoconstrictor Agents | 2003 |
LPO and antioxidant defense in the stomach of albino rats injected with angiotensin II and enalapril maleate.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Enalapril; Gastric Mucosa; Humans; Lipid Peroxides; Male; Rats; Stomach; Vasoconstrictor Agents | 2003 |
Angiotensin II dependent testicular fibrosis and effects on spermatogenesis after vasectomy in the rat.
Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Enalapril; Fibrosis; Heat-Shock Proteins; HSP47 Heat-Shock Proteins; Leydig Cells; Losartan; Male; Rats; Rats, Wistar; Spermatogenesis; Testis; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vasectomy | 2003 |
Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Division; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Enalapril; Humans; Indomethacin; Isoenzymes; Male; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptor, IGF Type 1; Sulfonamides | 2003 |
Differential regulation of in vivo angiogenesis by angiotensin II receptors.
Topics: Alginates; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Cell Line, Tumor; Enalapril; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Transgenic; Microspheres; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 2003 |
Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Enalapril; Losartan; Norepinephrine; Rats; Rats, Wistar; Renin-Angiotensin System; Time Factors; Vasoconstriction | 2003 |
Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Atrial Fibrillation; bcl-2-Associated X Protein; Biomarkers; Cardiac Pacing, Artificial; Caspase 3; Caspases; DNA Fragmentation; Dogs; Enalapril; Heart Atria; Heart Failure; In Situ Nick-End Labeling; Mitogen-Activated Protein Kinase Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2 | 2003 |
Induction of c-fos in forebrain circumventricular organs after renal artery stenosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Volume; Enalapril; Hemodynamics; Homeostasis; Hypothalamus; Immunohistochemistry; Kidney; Male; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Subfornical Organ; Up-Regulation; Visceral Afferents; Water-Electrolyte Balance | 2004 |
Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators.
Topics: Adrenal Cortex Hormones; Angiotensin II; Ascorbic Acid; Calcium Channel Blockers; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Enalapril; Endothelial Cells; Glutathione; Humans; Kidney Function Tests; Kidney Glomerulus; Malondialdehyde; Nephrosis; Oxidative Stress; Phytotherapy; Plants, Medicinal; Platelet Aggregation Inhibitors; Proteinuria; Reishi; Renal Circulation; Treatment Outcome; Vasodilator Agents; Vitamin E | 2003 |
Comparative effects of quinapril with enalapril in rats with heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathy, Dilated; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Fibrosis; Male; Myocardium; Quinapril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Tetrahydroisoquinolines; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Pressure | 2004 |
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium; Calcium-Transporting ATPases; Captopril; Cyclic AMP-Dependent Protein Kinases; Enalapril; Heart Failure; Imidazolidines; Losartan; Male; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Time Factors | 2004 |
Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Synergism; Enalapril; Fibrosis; Glomerulonephritis; Kidney; Male; Mice; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2004 |
Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm; Apolipoproteins E; Arteriosclerosis; Cell Adhesion Molecules; Chemokines; Enalapril; Endothelium; Gene Expression; Male; Mice; Mice, Knockout; PPAR alpha; PPAR gamma; RNA, Messenger; Up-Regulation; Vasculitis | 2005 |
Role of the renin-angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line; Enalapril; Folic Acid; Gentamicins; Kidney; Kidney Tubules; Losartan; Male; Parathyroid Hormone-Related Protein; Quinapril; Rats; Rats, Wistar; Receptor, Parathyroid Hormone, Type 1; Renin-Angiotensin System; Tetrahydroisoquinolines | 2005 |
Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II.
Topics: Amidohydrolases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diabetes Mellitus, Experimental; Enalapril; Liver; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Sulfotransferases | 2005 |
[Effects of enalapril on plasma Ang II level and the expression of AT1 in blood vessel and kidney of type 2 diabetic rats].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Diabetes Mellitus, Type 2; Dietary Fats; Enalapril; Endothelial Cells; Kidney; Male; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2005 |
Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Nucleus; Cumulative Trauma Disorders; Enalapril; Female; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Rats; Rats, Sprague-Dawley | 2005 |
[Effect of tianma gouteng recipe on interfering LV and aortic hypertrophy in renovascular hypertension rats].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Drug Combinations; Drugs, Chinese Herbal; Enalapril; Gastrodia; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Plants, Medicinal; Random Allocation; Rats; Rats, Wistar; Uncaria | 2005 |
Central angiotensin II controls alcohol consumption via its AT1 receptor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Brain; Dopamine; Enalapril; Mice; Mice, Inbred C57BL; Rats; Receptor, Angiotensin, Type 1 | 2005 |
Apoptosis of circulating lymphocyte in rats with unilateral ureteral obstruction: role of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Enalapril; Leukocyte Count; Losartan; Lymphocytes; Male; Rats; Rats, Wistar; Ureteral Obstruction | 2005 |
Angiotensin II inhibition attenuates postexercise proteinuria in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kallikrein-Kinin System; Losartan; Male; Physical Conditioning, Animal; Proteinuria; Rats; Rats, Wistar | 2005 |
Tubular mitochondrial alterations in neonatal rats subjected to RAS inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Blotting, Western; Enalapril; Immunohistochemistry; Kidney Tubules; Microscopy, Electron; Mitochondria; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 2006 |
Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enalapril; Gene Expression Regulation; Kidney Cortex; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2005 |
Androgens augment renal vascular responses to ANG II in New Zealand genetically hypertensive rats.
Topics: Age Factors; Androgens; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Enalapril; Gene Expression; Heart Rate; Hypertension; Kidney; Male; Orchiectomy; Organ Size; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Renal Artery; Renal Circulation; Testosterone | 2006 |
Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension.
Topics: Acetophenones; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Enalapril; Hypertension; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2005 |
Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Pressure; Cyclic N-Oxides; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enalapril; Eplerenone; Epoprostenol; Hypertension; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Inbred Dahl; Sodium Chloride; Spin Labels; Spironolactone; Treatment Outcome | 2006 |
Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Enalapril; Hemodynamics; Male; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction; Ventricular Function, Left | 2006 |
Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blotting, Western; Carrier Proteins; Enalapril; Enzyme Activation; Hypertension, Renal; Intracellular Signaling Peptides and Proteins; Kidney; Male; Orchiectomy; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Serine-Threonine Kinases; Rats; Rats, Mutant Strains; Renal Veins; rho-Associated Kinases; Signal Transduction; Testosterone; Vascular Resistance | 2006 |
The effects of angiotensin-converting enzyme inhibition on the urinary excretion of NTproBNP in male volunteers.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Hematocrit; Hormones; Humans; Kidney Function Tests; Luminescence; Male; Natriuretic Peptide, Brain; Peptide Fragments; Sodium; Water-Electrolyte Balance | 2006 |
Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Bradykinin; Chronic Disease; Cyclic N-Oxides; Dinoprost; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enalapril; Hydrogen Peroxide; Hypertension; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Spin Labels; Superoxides; Time Factors | 2007 |
Enalapril improves impairment of SERCA-derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Enalapril; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thapsigargin; Tyrosine | 2007 |
Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men.
Topics: Adiponectin; Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Depression, Chemical; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Enalapril; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Insulin; Leptin; Male; Renin; Renin-Angiotensin System; Sodium | 2007 |
Protective effect of long-term angiotensin II inhibition.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Body Weight; Cardiovascular System; Enalapril; Losartan; Male; Myocardium; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System | 2007 |
Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence.
Topics: Adaptation, Physiological; Alcoholism; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Animals, Genetically Modified; Central Nervous System; Disease Models, Animal; Enalapril; Ethanol; Humans; Neuronal Plasticity; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Antisense | 2007 |
Effects of angiotensin II blockade on the development of autoimmune thyroiditis in nonobese diabetic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalapril; Hashimoto Disease; Losartan; Mice; Mice, Inbred NOD; Sodium Iodide; Thyroglobulin | 2008 |
Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Endotoxemia; Imidazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Nitroprusside; Oxidative Stress; Renin-Angiotensin System; Superoxides; Tetrazoles; Vasodilation; Vasodilator Agents | 2007 |
Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Endothelium, Vascular; Humans; Imidazoles; Kidney Glomerulus; Losartan; Pyridines; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Shiga Toxin 1; Thromboplastin; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Drug Interactions; Eating; Enalapril; Estradiol; Female; Kidney Cortex; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sex Characteristics; Sodium Chloride, Dietary; Testosterone; Vasoconstrictor Agents | 2008 |
Enalapril treatment restores the decreased proximal tubule reabsorption in response to acute volume expansion in diabetic rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blood Volume; Diabetes Mellitus, Experimental; Enalapril; Glomerular Filtration Rate; Hydrostatic Pressure; Kidney Tubules, Proximal; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2008 |
[Interventions of enalapril on airway inflammation in rat models induced by acrolein].
Topics: Acrolein; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Bronchoalveolar Lavage Fluid; Enalapril; Immunohistochemistry; Lung; Male; NF-kappa B; Pneumonia; Random Allocation; Rats; Rats, Sprague-Dawley | 2008 |
Sexual dimorphism in the blood pressure response to angiotensin II in mice after angiotensin-converting enzyme blockade.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Catalase; Drug Synergism; Enalapril; F2-Isoprostanes; Female; Kidney Cortex; Male; Mice; Mice, Inbred C57BL; Proteinuria; Sex Characteristics; Superoxide Dismutase; Vasoconstrictor Agents | 2010 |
Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent.
Topics: Adenylyl Cyclases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Catecholamines; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enalapril; Female; GTP-Binding Protein alpha Subunits, Gs; Juxtaglomerular Apparatus; Male; Mice; Mice, Knockout; Models, Animal; Nitric Oxide; Prostaglandins; Renin; Signal Transduction; Tetrahydroisoquinolines; Tetrazoles | 2010 |
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cardiomegaly; Cell Enlargement; Cells, Cultured; Enalapril; Humans; Hypertrophy, Left Ventricular; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Myocytes, Cardiac; Norepinephrine; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left | 2010 |
Brain renin-angiotensin system modifies the blood pressure response to intracerebroventricular cadmium in rats.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Cadmium; Captopril; Clonidine; Enalapril; Heart; Histocytochemistry; Hypertension; Kallikrein-Kinin System; Kallikreins; Kidney; Male; Rats; Rats, Wistar; Renin-Angiotensin System; Saralasin | 2010 |
Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage via angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Gastric Mucosa; Hydrogen Peroxide; Male; NADPH Oxidases; Onium Compounds; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury | 2010 |
Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli.
Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Retinal Barrier; Calcium; Cells, Cultured; Enalapril; Epithelial Cells; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Losartan; Mice; Renin; Renin-Angiotensin System; Retinal Pigment Epithelium; Time Factors; Water Deprivation | 2010 |
Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Enalapril; Feasibility Studies; Male; Myocardial Reperfusion Injury; Myocardium; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Tissue Distribution; Valine; Valsartan | 2010 |
Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Collagen; Cyclic GMP; Disease Models, Animal; Enalapril; Hemodynamics; I-kappa B Proteins; Inflammation Mediators; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Phosphorylation; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor RelA; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Gene Expression; Kidney; Losartan; Male; MAP Kinase Signaling System; Nephritis; NF-kappa B; Oxidative Stress; Phosphorylation; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred F344; Transcription Factor RelA | 2011 |
Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats.
Topics: Acetylcholine; Angiotensin II; Animals; Enalapril; Endothelium, Vascular; Estrogens; Female; Free Radical Scavengers; NADPH Oxidases; Nitric Oxide; Ovariectomy; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Vasodilation | 2011 |
Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm; Aortic Rupture; Disease Models, Animal; Disease Progression; Enalapril; Losartan; MAP Kinase Signaling System; Marfan Syndrome; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptor, Angiotensin, Type 2; Signal Transduction; Transforming Growth Factor beta | 2011 |
Carboxypeptidase activity common to viridans group streptococci cleaves angiotensin I to angiotensin II: an activity homologous to angiotensin-converting enzyme (ACE).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Base Sequence; Captopril; Carboxypeptidases; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Enalapril; Endocarditis, Bacterial; Fibrinogen; Humans; Lisinopril; Molecular Sequence Data; Peptidyl-Dipeptidase A; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus gordonii | 2011 |
Angiotensin-converting enzyme inhibition augments the expression of rat elastase-2, an angiotensin II-forming enzyme.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Carotid Arteries; Disease Models, Animal; Enalapril; Hypertension; Immunohistochemistry; Male; Polymerase Chain Reaction; Rats; Rats, Inbred SHR; Rats, Wistar; RNA, Messenger; Serine Endopeptidases; Time Factors; Up-Regulation; Vasoconstriction | 2011 |
Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Humans; Male; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Oxidative Stress | 2011 |
Hypersensitivity to acute ANG II in female growth-restricted offspring is exacerbated by ovariectomy.
Topics: Angiotensin II; Animals; Animals, Newborn; Antihypertensive Agents; Blood Pressure; Body Weight; Enalapril; Female; Fetal Growth Retardation; Male; Models, Animal; Ovariectomy; Phenylephrine; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sex Characteristics; Vasoconstrictor Agents | 2011 |
Relationship between progesterone, oestrone sulphate and cortisol and the components of renin angiotensin aldosterone system in Spanish purebred broodmares during pregnancy.
Topics: Aldosterone; Angiotensin II; Animals; Enalapril; Estrone; Female; Horses; Hydrocortisone; Pregnancy; Pregnancy, Animal; Progesterone; Renin-Angiotensin System | 2011 |
Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Autonomic Nervous System; Blood Glucose; Blood Pressure; Blotting, Western; Body Weight; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electrocardiography; Enalapril; Heart; Heart Rate; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Function, Left | 2012 |
Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atherosclerosis; Blood Pressure; Cholesterol; Diet, High-Fat; Enalapril; Fumarates; Hypercholesterolemia; Kidney; Losartan; Male; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, LDL; Renin; Renin-Angiotensin System | 2012 |
Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aortic Coarctation; Cardiomegaly; Connexin 43; Enalapril; Fibrosis; Hydrogen Sulfide; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley | 2012 |
Increased activity of the renin-angiotensin and sympathetic nervous systems is required for regulation of the blood pressure in rats fed a low-protein diet.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterial Pressure; Diet, Protein-Restricted; Enalapril; Heart Rate; Losartan; Male; Prazosin; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sympathetic Nervous System | 2013 |
Perinatal Na+ overload programs raised renal proximal Na+ transport and enalapril-sensitive alterations of Ang II signaling pathways during adulthood.
Topics: Adenosine Triphosphatases; Aging; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Blood Pressure; Body Weight; Cation Transport Proteins; Creatinine; Cyclic AMP-Dependent Protein Kinases; Enalapril; Female; Gene Expression Regulation; Kidney Tubules, Proximal; Lipid Peroxidation; Macrophages; Male; Parturition; Pregnancy; Protein Kinase C; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction; Sodium; Sodium-Potassium-Exchanging ATPase; Thiobarbituric Acid Reactive Substances; Water; Weaning | 2012 |
An integrated physiology-based model for the interaction of RAA system biomarkers with drugs.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Computer Simulation; Enalapril; Enalaprilat; Humans; Injections, Intravenous; Models, Biological; Renin-Angiotensin System | 2012 |
Effects of angiotensin-converting enzyme inhibitory peptide LAP on vascular remodeling.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Vessels; Cell Nucleus Size; Collagen; Drug Design; Enalapril; Hypertension; Male; Oligopeptides; Rats; Rats, Inbred SHR; Tunica Media | 2013 |
Sex differences in the enhanced responsiveness to acute angiotensin II in growth-restricted rats: role of fasudil, a Rho kinase inhibitor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Blood Pressure; Castration; Enalapril; Female; Fetal Growth Retardation; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; Placental Insufficiency; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Renal Circulation; Renin-Angiotensin System; rho-Associated Kinases; Sex Characteristics; Vascular Resistance | 2013 |
Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Topics: Adenoviridae; Adenoviridae Infections; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Connective Tissue Growth Factor; Enalapril; Fibrosis; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Animal; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1 | 2013 |
Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atherosclerosis; Bone Marrow Transplantation; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Enalapril; Hypercholesterolemia; Leukocytes; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidyl-Dipeptidase A; Receptors, LDL; Transplantation Chimera | 2013 |
Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Autoantibodies; Blood Pressure; Enalapril; Endothelin-1; Female; Hypertension, Pregnancy-Induced; Kidney; Oxidative Stress; Placenta; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1 | 2013 |
Angiotensin-converting enzyme inhibitor (enalapril maleate) accelerates recovery of mouse skin from UVB-induced wrinkles.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Epidermis; Male; Mice; Mice, Hairless; Recovery of Function; Signal Transduction; Skin Aging; Ultraviolet Rays | 2013 |
Interference of angiotensin II and enalapril with hepatic blood flow regulation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Pressure; Cardiac Output; Carotid Arteries; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Enalapril; Hemodynamics; Hepatic Artery; Liver Circulation; Male; Portal Vein; Renal Artery; Renal Circulation; Swine; Time Factors | 2014 |
AT1 receptor blocker losartan protects against mechanical ventilation-induced diaphragmatic dysfunction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diaphragm; Enalapril; Female; Losartan; Muscle Weakness; Rats; Rats, Sprague-Dawley; Respiration, Artificial | 2015 |
Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Blood Pressure; Blotting, Western; Enalapril; Endothelin Receptor Antagonists; Endothelin-1; Female; Fetal Growth Retardation; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; Ovariectomy; Pregnancy; Pyrrolidines; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; Sex Factors | 2015 |
Renal oxidative stress and renal CD8(+) T-cell infiltration in mercuric chloride-induced nephropathy in rats: role of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Catalase; CD8-Positive T-Lymphocytes; Enalapril; Glutathione; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; Mercuric Chloride; Necrosis; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2016 |
The effect of angiotensin-converting enzyme inhibition throughout a superovulation protocol in ewes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Embryo, Nonmammalian; Enalapril; Estradiol; Female; Ovulation; Peptide Fragments; Peptidyl-Dipeptidase A; Progesterone; Sheep; Superovulation | 2015 |
Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Enalapril; Female; Hypertension; Kidney; Male; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2015 |
Enalapril protects against myocardial ischemia/reperfusion injury in a swine model of cardiac arrest and resuscitation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Cardiopulmonary Resuscitation; Cardiotonic Agents; Disease Models, Animal; Enalapril; Gene Expression; Heart; Heart Arrest; Humans; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Myocardial Reperfusion Injury; Myocardium; Peptidyl-Dipeptidase A; Random Allocation; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Swine; Time Factors; Ventricular Fibrillation | 2016 |
Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Diltiazem; Disease Progression; Enalapril; Gene Expression Regulation; Heart; Kidney; Male; Organ Size; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Regional Blood Flow; Renal Insufficiency, Chronic | 2017 |
Capillary rarefaction and altered renal development: the imbalance between pro- and anti-angiogenic factors in response to angiotensin II inhibition in the developing rat kidney.
Topics: Angiogenesis Modulating Agents; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Enalapril; Kidney; Microvascular Rarefaction; Rats | 2018 |
Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antidepressive Agents; Captopril; Carbazoles; Cells, Cultured; Cerebral Cortex; Enalapril; Hippocampus; Imidazoles; Immobility Response, Tonic; Indole Alkaloids; Losartan; Male; Mice; Microinjections; Prefrontal Cortex; Proto-Oncogene Proteins c-fyn; Pyridines; Rats; Receptor, Angiotensin, Type 2; Receptor, trkB; Transcriptional Activation | 2018 |
Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enalapril; Female; Glucagon-Like Peptide 1; Humans; Hypertension; Linagliptin; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate | 2019 |
Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value.
Topics: Acute Coronary Syndrome; ADAM17 Protein; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Enalapril; Female; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Kaplan-Meier Estimate; Losartan; Male; Metoprolol; Middle Aged; Peptidyl-Dipeptidase A; Prognosis | 2021 |
Effect of angiotensin II pathway inhibitors on post-surgical adhesion band formation: a potential repurposing of old drugs.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Drug Repositioning; Enalapril; Eosine Yellowish-(YS); Fibrosis; Hematoxylin; Inflammation; Pharmaceutical Preparations; Rats; Rats, Wistar; Sulfhydryl Compounds; Superoxide Dismutase; Telmisartan; Tissue Adhesions | 2022 |